<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rite="http://mineralrite.com/20251231"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rite-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesBPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesBPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesBPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesBPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesCPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesCPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesCPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesCPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesDPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesDPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesDPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesDPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212182609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_custom_SeriesNMCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesBPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesBPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesBPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesBPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesCPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesCPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesCPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesDPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesDPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesDPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesDPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember212182640">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesAPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesAPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesBPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesBPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesCPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesCPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesDPreferredStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesDPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember212182656">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember212183687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_WarrantMember_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_PeeplesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rite:PeeplesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember212184531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212184531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rite:SeriesNMCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MineTailingsAndPermittingServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rite:MineTailingsAndPermittingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PeeplesMineralLeaseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rite:PeeplesMineralLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CaliforniaPreciousMetalsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rite:CaliforniaPreciousMetalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_GoodwillsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rite:GoodwillsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_UndesignatedPreferredstockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:UndesignatedPreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_UndesignatedPreferredstockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:UndesignatedPreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesCPreferredStocksMember212187796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesCPreferredStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesCContractualPurchaseRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesCContractualPurchaseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesCWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesDWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesDWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesNMCWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SeriesNMCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_SeriesNMCConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rite:SeriesNMCConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-02-012025-02-28_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-10-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_CommonStockMember212189015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_AbstractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:AbstractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AbstractMember_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:AbstractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_AbstractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:AbstractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_CommodityCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:CommodityCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_CommodityCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:CommodityCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_CommodityCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:CommodityCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:MISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AbstractMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">rite:AbstractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_srt_PresidentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:PresidentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2026-01-31_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-31</instant>
        </period>
    </context>
    <context id="From2026-01-012026-01-31_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-10_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-10_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096296</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-10</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2025-01-01to2025-12-31" id="Fact000005">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-01-01to2025-12-31" id="Fact000006">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000007">0001096296</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0019">TX</dei:EntityIncorporationStateCountryCode>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0069"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0070"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0072"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InventoryNet
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0073"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:EmployeeAdvancesCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0075"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:EmployeeAdvancesCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0076"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0078"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0079"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Investments
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0103"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:MineralRoyalties
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0106"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0108"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:LiabilityDueToCommittedSharesInExcessOfAuthorized
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0135"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:LiabilityDueToCommittedSharesInExcessOfAuthorized
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0136"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0144"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0150"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilities
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0151"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      id="xdx2ixbrl0215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2024-12-31"
      id="xdx2ixbrl0262"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0273"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CostOfRevenue
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0277"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GrossProfit
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0282"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0285"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0306"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:Storage
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0351"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingExpense
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0352"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0354"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:UnrealizedGainLoss
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0367"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSharesSeriesCPreferredIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodSharesSeriesCPreferredIssuedForServices
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0398"
      unitRef="Shares"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSharesSeriesCPreferredIssuedForServices
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSharesSeriesDPreferredIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609"
      id="xdx2ixbrl0404"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodSharesSeriesDPreferredIssuedForServices
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0406"
      unitRef="Shares"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSharesSeriesDPreferredIssuedForServices
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0426"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0430"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesAPreferredStocksMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesBPreferredStocksMember"
      id="xdx2ixbrl0450"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesBPreferredStocksMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesBPreferredStocksMember"
      id="xdx2ixbrl0454"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesBPreferredStocksMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodSharesIssuedForServicesShares
      contextRef="From2024-01-012024-12-31_custom_SeriesCPreferredStocksMember"
      id="xdx2ixbrl0486"
      unitRef="Shares"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSharesIssuedForServicesShares
      contextRef="From2024-01-012024-12-31_custom_SeriesCPreferredStocksMember"
      id="xdx2ixbrl0488"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl0502"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-01-012024-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl0518"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-01-012024-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl0522"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesNMCPreferredStockMember"
      id="xdx2ixbrl0534"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_SeriesNMCPreferredStockMember"
      id="xdx2ixbrl0536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember212182640"
      id="xdx2ixbrl0538"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0558"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:ExcessFromCommonStockFairValueOverPar
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:ExcessFromSeriesNmcFairValueOverPar
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0566"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSeriesCPreferredIssuedForServices
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0572"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:StockIssuedDuringPeriodValueSeriesDPreferredIssuedForServices
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:ConversionOfObligationsIntoWarrants
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Depreciation
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0616"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:GainLossOnExtinguishmentOfObligationsWarrantsIssued
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0624"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0627"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0628"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:IncreaseDecreaseInReceivablesAndPrepaids
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0630"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0633"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:OtherAdjustmentsNet
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0640"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0649"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0651"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfOilAndGasPropertyAndEquipment
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0652"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0654"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0655"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0657"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0658"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0661"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0670"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromInsurancePremiumsCollected
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0673"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0679"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:PaymentOfDividends
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl0681"
      unitRef="USD"
      xsi:nil="true"/>
    <rite:PaymentOfDividends
      contextRef="From2024-01-012024-12-31"
      id="xdx2ixbrl0682"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="xdx2ixbrl0852"
      unitRef="USD">432011500</us-gaap:MineralPropertiesGross>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0854"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl1048"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesDPreferredStocksMember"
      id="xdx2ixbrl1050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl1126"
      unitRef="Shares"
      xsi:nil="true"/>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-01to2025-12-31"
      id="xdx2ixbrl1128"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="xdx2ixbrl1164"
      unitRef="USDPShares">0.000065</us-gaap:EarningsPerShareDiluted>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2025-01-01to2025-12-31" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-01-01to2025-12-31" id="Fact000015">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2025-01-01to2025-12-31" id="Fact000016">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-01-01to2025-12-31" id="Fact000017">000-27739</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000018">MINERALRITE         CORPORATION</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-01-01to2025-12-31" id="Fact000020">90-0315909</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-01-01to2025-12-31" id="Fact000021">325 N. St. Paul Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-01-01to2025-12-31" id="Fact000022">Suite 3100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-01-01to2025-12-31" id="Fact000023">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-01-01to2025-12-31" id="Fact000024">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-01-01to2025-12-31" id="Fact000025">75201</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-01-01to2025-12-31" id="Fact000026">469</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-01-01to2025-12-31" id="Fact000027">881-8900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      id="Fact000028">Common stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      id="Fact000029">RITE</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesAPreferredStockMember"
      id="Fact000030">Series A Preferred</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember"
      id="Fact000031">Series B Preferred</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      id="Fact000032">Series C Preferred</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      id="Fact000033">Series D Preferred</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember"
      id="Fact000034">Series NMC Preferred</dei:Security12bTitle>
    <dei:EntityCurrentReportingStatus contextRef="From2025-01-01to2025-12-31" id="Fact000035">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-01-01to2025-12-31" id="Fact000036">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-01-01to2025-12-31" id="Fact000037">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-01-01to2025-12-31" id="Fact000038">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-01-01to2025-12-31" id="Fact000039">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2025-01-01to2025-12-31" id="Fact000040">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="From2025-01-01to2025-12-31" id="Fact000041">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000042"
      unitRef="Shares">6211776842</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityVoluntaryFilers contextRef="From2025-01-01to2025-12-31" id="Fact000043">No</dei:EntityVoluntaryFilers>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2025-01-01to2025-12-31" id="Fact000044">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2025-01-01to2025-12-31" id="Fact000045">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityPublicFloat
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000046"
      unitRef="USD">0</dei:EntityPublicFloat>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000050">The Company recognizes the importance of
maintaining the security and integrity of its information systems and data. The Company&#x2019;s operations currently involve limited
information technology infrastructure, consisting primarily of standard business systems, cloud-based accounting platforms, and
administrative communication tools.The Company has implemented basic cybersecurity
measures appropriate to its size and stage of development, including password protection, access controls, data backup procedures,
and the use of reputable &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90A_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20250101__20251231_zCVYALCPXK9f"&gt;third-party&lt;/span&gt; service providers with established cybersecurity protections.&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has not experienced any cybersecurity
incidents that have materially affected, or are reasonably likely to materially affect, the Company&#x2019;s business strategy,
results of operations, or financial condition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20250101__20251231_zYUDAAs4Pbo7"&gt;Management is responsible for overseeing
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_ztlqHDjEBJEe"&gt;cybersecurity risk&lt;/span&gt; and periodically evaluates the Company&#x2019;s information technology systems and service providers to identify
potential risks and implement appropriate safeguards.&lt;/span&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000051">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000052">Management is responsible for overseeing
&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250101__20251231_ztlqHDjEBJEe"&gt;cybersecurity risk&lt;/span&gt; and periodically evaluates the Company&#x2019;s information technology systems and service providers to identify
potential risks and implement appropriate safeguards.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000053">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <dei:AuditorOpinionTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000055">&lt;b&gt;&lt;i&gt;Opinion on the Financial Statements&lt;/i&gt;&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;We have audited the accompanying financial
statements of MineralRite Corporation (a Texas Corporation) and subsidiaries, which comprise the balance sheets as of December
31, 2025, and 2024, and the related statements of operations, changes in stockholders&#x2019; equity (deficit) and cash flows for
the years then ended, and the related notes to the financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In our opinion, the financial statements
referred to above present fairly, in all material respects, the financial position of MineralRite Corporation as of December 31,
2025, and 2024, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles
generally accepted in the United States of America.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="From2025-01-01to2025-12-31" id="Fact000056">Zhanna Kelley CPA PC</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2025-01-01to2025-12-31" id="Fact000057">Long Island City, New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2025-01-01to2025-12-31" id="Fact000058">6888</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">11617</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">10458</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000081"
      unitRef="USD">134363</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000082"
      unitRef="USD">6496</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000084"
      unitRef="USD">145980</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000085"
      unitRef="USD">16954</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000090"
      unitRef="USD">438414</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000091"
      unitRef="USD">438414</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000093"
      unitRef="USD">198414</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000094"
      unitRef="USD">198414</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000096"
      unitRef="USD">240000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000097"
      unitRef="USD">240000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Investments
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000102"
      unitRef="USD">51300</us-gaap:Investments>
    <rite:MineralRoyalties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000105"
      unitRef="USD">1380000</rite:MineralRoyalties>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000111"
      unitRef="USD">432011500</us-gaap:MineralPropertiesGross>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000112"
      unitRef="USD">432000000</us-gaap:MineralPropertiesGross>
    <us-gaap:OtherAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000117"
      unitRef="USD">433442800</us-gaap:OtherAssets>
    <us-gaap:OtherAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000118"
      unitRef="USD">432000000</us-gaap:OtherAssets>
    <us-gaap:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000120"
      unitRef="USD">433828780</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000121"
      unitRef="USD">432256954</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000129"
      unitRef="USD">48948</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000130"
      unitRef="USD">30766</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000132"
      unitRef="USD">4997300</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="USD">5000000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000138"
      unitRef="USD">5046248</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000139"
      unitRef="USD">5030766</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000145"
      unitRef="USD">117500</us-gaap:ConvertibleDebt>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000147"
      unitRef="USD">15520</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000148"
      unitRef="USD">28222</us-gaap:NotesPayable>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000153"
      unitRef="USD">15520</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000154"
      unitRef="USD">145722</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000156"
      unitRef="USD">5061768</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000157"
      unitRef="USD">5176488</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000162"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000164"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000166"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000168"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000170"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000172"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact000173"
      unitRef="USD">105</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact000174"
      unitRef="USD">105</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000176"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000178"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000180"
      unitRef="Shares">33000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000182"
      unitRef="Shares">33000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000184"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000186"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact000187"
      unitRef="USD">14</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact000188"
      unitRef="USD">14</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000190"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000192"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000194"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000196"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000198"
      unitRef="Shares">9404</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000200"
      unitRef="Shares">8249</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact000201"
      unitRef="USD">828585</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact000202"
      unitRef="USD">499485</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000204"
      unitRef="USDPShares">25</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000206"
      unitRef="USDPShares">25</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000208"
      unitRef="Shares">35000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000210"
      unitRef="Shares">35000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000212"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000214"
      unitRef="Shares">700</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="Fact000216"
      unitRef="USD">17500</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000218"
      unitRef="USDPShares">25</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000220"
      unitRef="USDPShares">25</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000222"
      unitRef="Shares">7100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000224"
      unitRef="Shares">7100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000226"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000228"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="0"
      id="Fact000229"
      unitRef="USD">172500000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="0"
      id="Fact000230"
      unitRef="USD">172500000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000232"
      unitRef="Shares">42627000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000234"
      unitRef="Shares">42627000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000236"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000238"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000243"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000245"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000247"
      unitRef="Shares">20000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000249"
      unitRef="Shares">20000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000251"
      unitRef="Shares">6211776842</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000253"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000240"
      unitRef="USD">3887635</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000241"
      unitRef="USD">3887635</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000255"
      unitRef="USD">256312494</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000256"
      unitRef="USD">254646029</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000258"
      unitRef="USD">-4761821</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000259"
      unitRef="USD">-4470302</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000264"
      unitRef="USD">428767012</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000265"
      unitRef="USD">427080466</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000267"
      unitRef="USD">433828780</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000268"
      unitRef="USD">432256954</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000274"
      unitRef="USD">5000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000280"
      unitRef="USD">5000</us-gaap:GrossProfit>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000286"
      unitRef="USD">5000</us-gaap:Revenues>
    <rite:AccountingAndAuditing
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000291"
      unitRef="USD">5600</rite:AccountingAndAuditing>
    <rite:AccountingAndAuditing
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000292"
      unitRef="USD">4062</rite:AccountingAndAuditing>
    <rite:BankCharges
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000294"
      unitRef="USD">195</rite:BankCharges>
    <rite:BankCharges
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000295"
      unitRef="USD">430</rite:BankCharges>
    <us-gaap:BusinessDevelopment
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000297"
      unitRef="USD">26258</us-gaap:BusinessDevelopment>
    <us-gaap:BusinessDevelopment
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000298"
      unitRef="USD">5104</us-gaap:BusinessDevelopment>
    <rite:BusinessTravel
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000300"
      unitRef="USD">10468</rite:BusinessTravel>
    <rite:BusinessTravel
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000301"
      unitRef="USD">6065</rite:BusinessTravel>
    <us-gaap:Communication
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000303"
      unitRef="USD">784</us-gaap:Communication>
    <us-gaap:Communication
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000304"
      unitRef="USD">792</us-gaap:Communication>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000307"
      unitRef="USD">121648</us-gaap:DepreciationDepletionAndAmortization>
    <rite:FilingsAndCorpCleaning
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000309"
      unitRef="USD">28504</rite:FilingsAndCorpCleaning>
    <rite:FilingsAndCorpCleaning
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000310"
      unitRef="USD">16642</rite:FilingsAndCorpCleaning>
    <us-gaap:ProfessionalFees
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000312"
      unitRef="USD">282300</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000313"
      unitRef="USD">189650</us-gaap:ProfessionalFees>
    <us-gaap:MarketingExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">10500</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000316"
      unitRef="USD">8280</us-gaap:MarketingExpense>
    <rite:OfficeExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000318"
      unitRef="USD">55132</rite:OfficeExpense>
    <rite:OfficeExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000319"
      unitRef="USD">2580</rite:OfficeExpense>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000321"
      unitRef="USD">67</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000322"
      unitRef="USD">27</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000324"
      unitRef="USD">8058</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000325"
      unitRef="USD">10237</us-gaap:ResearchAndDevelopmentExpense>
    <rite:Storage
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000328"
      unitRef="USD">500</rite:Storage>
    <us-gaap:EquipmentExpense
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000330"
      unitRef="USD">597</us-gaap:EquipmentExpense>
    <us-gaap:EquipmentExpense
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000331"
      unitRef="USD">679</us-gaap:EquipmentExpense>
    <rite:TransferAgent
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000333"
      unitRef="USD">4054</rite:TransferAgent>
    <rite:TransferAgent
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000334"
      unitRef="USD">2000</rite:TransferAgent>
    <rite:WebAndComputerServices
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000336"
      unitRef="USD">2302</rite:WebAndComputerServices>
    <rite:WebAndComputerServices
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000337"
      unitRef="USD">2920</rite:WebAndComputerServices>
    <us-gaap:OperatingExpenses
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000339"
      unitRef="USD">434819</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000340"
      unitRef="USD">371616</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000342"
      unitRef="USD">-434819</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000343"
      unitRef="USD">-366616</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000348"
      unitRef="USD">117500</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000349"
      unitRef="USD">763378</us-gaap:OtherNonoperatingIncome>
    <rite:UnrealizedGainLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000360"
      unitRef="USD">-25800</rite:UnrealizedGainLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000363"
      unitRef="USD">-291519</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000364"
      unitRef="USD">396762</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000369"
      unitRef="USD">-291519</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000370"
      unitRef="USD">396762</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000372"
      unitRef="USDPShares">-0.00006</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000373"
      unitRef="USDPShares">0.000089</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact000375"
      unitRef="USDPShares">-0.00006</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000376"
      unitRef="USDPShares">0.000065</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000378"
      unitRef="Shares">4347776842</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000380"
      unitRef="USD">3887635</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000382"
      unitRef="Shares">4357321532</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000384"
      unitRef="USD">3887635</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609"
      decimals="INF"
      id="Fact000386"
      unitRef="Shares">22000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000390"
      unitRef="Shares">-9544690</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <rite:StockIssuedDuringPeriodSharesSeriesCPreferredIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609"
      decimals="INF"
      id="Fact000394"
      unitRef="Shares">342000000</rite:StockIssuedDuringPeriodSharesSeriesCPreferredIssuedForServices>
    <rite:StockIssuedDuringPeriodSharesSeriesDPreferredIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember212182609"
      decimals="INF"
      id="Fact000402"
      unitRef="Shares">1500000000</rite:StockIssuedDuringPeriodSharesSeriesDPreferredIssuedForServices>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000410"
      unitRef="Shares">6211776842</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000412"
      unitRef="USD">3887635</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000414"
      unitRef="Shares">4347776842</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000416"
      unitRef="USD">3887635</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      id="Fact000418"
      unitRef="Shares">105000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesAPreferredStocksMember"
      decimals="0"
      id="Fact000420"
      unitRef="USD">105</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      id="Fact000422"
      unitRef="Shares">105000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_SeriesAPreferredStocksMember"
      decimals="0"
      id="Fact000424"
      unitRef="USD">105</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      id="Fact000434"
      unitRef="Shares">105000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesAPreferredStocksMember"
      decimals="0"
      id="Fact000436"
      unitRef="USD">105</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesAPreferredStocksMember"
      decimals="INF"
      id="Fact000438"
      unitRef="Shares">105000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesAPreferredStocksMember"
      decimals="0"
      id="Fact000440"
      unitRef="USD">105</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBPreferredStocksMember"
      decimals="INF"
      id="Fact000442"
      unitRef="Shares">13500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesBPreferredStocksMember"
      decimals="0"
      id="Fact000444"
      unitRef="USD">14</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesBPreferredStocksMember"
      decimals="INF"
      id="Fact000446"
      unitRef="Shares">13500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_SeriesBPreferredStocksMember"
      decimals="0"
      id="Fact000448"
      unitRef="USD">14</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesBPreferredStocksMember"
      decimals="INF"
      id="Fact000458"
      unitRef="Shares">13500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesBPreferredStocksMember"
      decimals="0"
      id="Fact000460"
      unitRef="USD">14</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesBPreferredStocksMember"
      decimals="INF"
      id="Fact000462"
      unitRef="Shares">13500</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesBPreferredStocksMember"
      decimals="0"
      id="Fact000464"
      unitRef="USD">14</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000466"
      unitRef="Shares">8249</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000468"
      unitRef="USD">499485</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000470"
      unitRef="Shares">6050</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000472"
      unitRef="USD">70005</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000474"
      unitRef="Shares">2010</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000476"
      unitRef="USD">431700</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000478"
      unitRef="Shares">2199</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000480"
      unitRef="USD">429480</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <rite:StockIssuedDuringPeriodSharesIssuedForServicesShares
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000482"
      unitRef="Shares">-855</rite:StockIssuedDuringPeriodSharesIssuedForServicesShares>
    <rite:StockIssuedDuringPeriodValueSharesIssuedForServicesShares
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000484"
      unitRef="USD">-102600</rite:StockIssuedDuringPeriodValueSharesIssuedForServicesShares>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000490"
      unitRef="Shares">9404</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000492"
      unitRef="USD">828585</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact000494"
      unitRef="Shares">8249</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact000496"
      unitRef="USD">499485</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="INF"
      id="Fact000498"
      unitRef="Shares">700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="0"
      id="Fact000500"
      unitRef="USD">17500</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesDPreferredStocksMember"
      decimals="INF"
      id="Fact000506"
      unitRef="Shares">59300</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesDPreferredStocksMember"
      decimals="0"
      id="Fact000508"
      unitRef="USD">1482500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="INF"
      id="Fact000510"
      unitRef="Shares">700</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="0"
      id="Fact000512"
      unitRef="USD">17500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-01-012025-12-31_custom_SeriesDPreferredStocksMember"
      decimals="INF"
      id="Fact000514"
      unitRef="Shares">-60000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-012025-12-31_custom_SeriesDPreferredStocksMember"
      decimals="0"
      id="Fact000516"
      unitRef="USD">-1500000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="INF"
      id="Fact000526"
      unitRef="Shares">700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="0"
      id="Fact000528"
      unitRef="USD">17500</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212182609"
      decimals="INF"
      id="Fact000530"
      unitRef="Shares">6900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212182609"
      decimals="0"
      id="Fact000532"
      unitRef="USD">172500000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000540"
      unitRef="Shares">6900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="0"
      id="Fact000542"
      unitRef="USD">172500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember212182656"
      decimals="INF"
      id="Fact000544"
      unitRef="Shares">6900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember212182656"
      decimals="0"
      id="Fact000546"
      unitRef="USD">172500000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212182609"
      decimals="INF"
      id="Fact000548"
      unitRef="Shares">6900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212182609"
      decimals="0"
      id="Fact000550"
      unitRef="USD">172500000</us-gaap:StockholdersEquity>
    <rite:StockholdersEquityTotal
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000552"
      unitRef="USD">177216339</rite:StockholdersEquityTotal>
    <rite:StockholdersEquityTotal
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000554"
      unitRef="USD">176904739</rite:StockholdersEquityTotal>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000556"
      unitRef="USD">254646029</us-gaap:StockholdersEquity>
    <rite:ExcessFromCommonStockFairValueOverPar
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000560"
      unitRef="USD">56500</rite:ExcessFromCommonStockFairValueOverPar>
    <rite:ExcessFromSeriesCFairValueOverPar
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000564"
      unitRef="USD">5000</rite:ExcessFromSeriesCFairValueOverPar>
    <rite:ExcessFromSeriesNmcFairValueOverPar
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000568"
      unitRef="USD">254500000</rite:ExcessFromSeriesNmcFairValueOverPar>
    <rite:StockIssuedDuringPeriodValueSeriesCPreferredIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000570"
      unitRef="USD">102600</rite:StockIssuedDuringPeriodValueSeriesCPreferredIssuedForServices>
    <rite:StockIssuedDuringPeriodValueSeriesDPreferredIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000574"
      unitRef="USD">1500000</rite:StockIssuedDuringPeriodValueSeriesDPreferredIssuedForServices>
    <rite:ConversionOfObligationsIntoWarrants
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000580"
      unitRef="USD">137499</rite:ConversionOfObligationsIntoWarrants>
    <rite:OpenOptionContractWrittenPremiums
      contextRef="From2025-01-012025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000582"
      unitRef="USD">2365</rite:OpenOptionContractWrittenPremiums>
    <rite:OpenOptionContractWrittenPremiums
      contextRef="From2024-01-012024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000584"
      unitRef="USD">8530</rite:OpenOptionContractWrittenPremiums>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000586"
      unitRef="USD">256312494</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000588"
      unitRef="USD">254646029</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000590"
      unitRef="USD">-4470302</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000592"
      unitRef="USD">-4867064</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-012025-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000594"
      unitRef="USD">-291519</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000596"
      unitRef="USD">396762</us-gaap:ProfitLoss>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000598"
      unitRef="USD">-4761821</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000600"
      unitRef="USD">-4470302</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000602"
      unitRef="USD">428767012</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000604"
      unitRef="USD">427080466</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000609"
      unitRef="USD">-291519</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000610"
      unitRef="USD">396762</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000613"
      unitRef="USD">121648</us-gaap:Depreciation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000615"
      unitRef="USD">81733</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000618"
      unitRef="USD">25800</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000621"
      unitRef="USD">117500</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000622"
      unitRef="USD">763377</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <rite:GainLossOnExtinguishmentOfObligationsWarrantsIssued
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000625"
      unitRef="USD">137499</rite:GainLossOnExtinguishmentOfObligationsWarrantsIssued>
    <rite:IncreaseDecreaseInReceivablesAndPrepaids
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000631"
      unitRef="USD">6496</rite:IncreaseDecreaseInReceivablesAndPrepaids>
    <rite:IncreaseDecreaseInAccruedLiabilitiy
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000636"
      unitRef="USD">49382</rite:IncreaseDecreaseInAccruedLiabilitiy>
    <rite:IncreaseDecreaseInAccruedLiabilitiy
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000637"
      unitRef="USD">10552</rite:IncreaseDecreaseInAccruedLiabilitiy>
    <rite:OtherAdjustmentsNet
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000639"
      unitRef="USD">2700</rite:OtherAdjustmentsNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000642"
      unitRef="USD">-306404</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000643"
      unitRef="USD">-378410</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000648"
      unitRef="USD">11500</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000660"
      unitRef="USD">-11500</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000667"
      unitRef="USD">353009</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000669"
      unitRef="USD">203900</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromInsurancePremiumsCollected
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000672"
      unitRef="USD">2365</us-gaap:ProceedsFromInsurancePremiumsCollected>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000675"
      unitRef="USD">125500</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000676"
      unitRef="USD">28222</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000678"
      unitRef="USD">12702</us-gaap:RepaymentsOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000684"
      unitRef="USD">319063</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000685"
      unitRef="USD">381231</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000690"
      unitRef="USD">1159</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000691"
      unitRef="USD">2821</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000693"
      unitRef="USD">10458</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2023-12-31"
      decimals="0"
      id="Fact000694"
      unitRef="USD">7637</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000696"
      unitRef="USD">11617</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000697"
      unitRef="USD">10458</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <rite:StockIssuedForServicesTotalContractualValue
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000705"
      unitRef="USD">209600</rite:StockIssuedForServicesTotalContractualValue>
    <rite:ConversionOfShortTermNotesPayableIntoEquityExerciseOfOptions
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000708"
      unitRef="USD">125500</rite:ConversionOfShortTermNotesPayableIntoEquityExerciseOfOptions>
    <rite:ReductionOfAccountsPayableViaOptionExerciseBillOffsetTransaction
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000711"
      unitRef="USD">31200</rite:ReductionOfAccountsPayableViaOptionExerciseBillOffsetTransaction>
    <rite:NoncashIssuanceOfSeriesDConvertiblePreferredStock
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000714"
      unitRef="USD">1380000</rite:NoncashIssuanceOfSeriesDConvertiblePreferredStock>
    <rite:IssuanceOfCommonForInvestmentNoncashTransaction
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000720"
      unitRef="USD">25500</rite:IssuanceOfCommonForInvestmentNoncashTransaction>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000723">&lt;p id="xdx_802_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zlr41dOi2Cm1" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(1) &lt;span id="xdx_821_zBhe6lv9pMkd"&gt;Nature of Business / Organization and Basis of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Nature of Business&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;MineralRite Corporation (&#x201c;MineralRite,&#x201d;
&#x201c;RITE,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) is a Texas-based mineral
and mine management and monetization company. The Company&#x2019;s business model is focused on the acquisition, evaluation, development,
and monetization of mineral assets, with an emphasis on previously processed tailings, above-ground materials, and other resource
opportunities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s strategy is to identify
mineral assets that can be advanced through technical evaluation, regulatory compliance, and operational planning, and then monetized
through production, joint ventures, project-level financing, or strategic transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company currently operates in a development
stage and has not yet generated significant operating revenue from its principal mineral-asset activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Corporate History and Change in Control&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company traces its origins to a Nevada
corporation formed in 1996. Over time, the Company experienced multiple changes in control, business direction, and capital structure.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In April 2021, the Company completed an
F-reorganization merger and re-domiciled to the State of Texas. This transaction was intended to simplify the Company&#x2019;s corporate
structure and align it with its anticipated business direction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In October 2023, a change in control occurred
when current management acquired voting control of the Company and assumed operational leadership. Following this transition, management
initiated a comprehensive restructuring of the Company&#x2019;s accounting, capital structure, and business operations. These efforts
included the settlement or restructuring of certain legacy obligations, revisions to the capital structure, and a strategic shift
toward mineral asset acquisition, development, and monetization.&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result of this change in control and
subsequent restructuring, the Company&#x2019;s current business model, capital structure, and operating strategy differ substantially
from those that existed under prior management.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;December 31, 2024, Acquisition&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 31, 2024, the Company completed
the acquisition of 100% of the equity interests of California Precious Metals LLC and Peeples, Inc., two wholly owned subsidiaries
of NMC, Inc.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The acquisition included:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Two mineral leases held by California Precious Metals LLC, and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Previously processed mine tailings and a mineral lease held by Peeples, Inc.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The acquired set related to Peeples, Inc.
also included a written mine development plan, technical documentation, recovery methodologies, and industry relationships relevant
to the advancement of the project.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Total consideration for the transaction
consisted of:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pn5n6_uShares_c20240101__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zGMKmjsmpknf" title="Issuance of shares"&gt;6.9&lt;/span&gt; million shares of Series NMC $&lt;span id="xdx_900_ecustom--ProceedFromIssuanceOfConvertiblePreferredStock_uUSD_c20240101__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertiblePreferredStockMember_zT7cKBXoZox1" title="Convertible preferred stock"&gt;25&lt;/span&gt; Convertible Preferred Stock, and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pp5n6_uShares_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_zf35eU0JWld9" title="Warrants"&gt;6.9&lt;/span&gt; million warrants to acquire additional Series NMC preferred shares.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The aggregate transaction value was approximately
$&lt;span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferred1_pn6n6_uUSD_c20240101__20241231_zRDsSojZtVMd" title="Business combination value"&gt;432&lt;/span&gt; million, and the Company assumed approximately $&lt;span id="xdx_90D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn6n6_uUSD_c20241231__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_zQlRfPdF5I3" title="Business combination value"&gt;5&lt;/span&gt; million in liabilities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The acquisition of Peeples, Inc. was accounted
for as a business combination under ASC 805, while the California Precious Metals LLC component was treated as an asset acquisition.
The assets and liabilities acquired in this transaction form a significant portion of the Company&#x2019;s consolidated balance
sheet as of December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Organizational Structure&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company conducts its operations through
wholly owned subsidiaries, each of which is intended to hold specific mineral assets or project interests. This structure is designed
to isolate project-level risks, facilitate financing arrangements, and allow for separate development or monetization strategies
for individual properties.&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember212183687"
      decimals="-5"
      id="Fact000726"
      unitRef="Shares">6900000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <rite:ProceedFromIssuanceOfConvertiblePreferredStock
      contextRef="From2024-01-012024-12-31_us-gaap_ConvertiblePreferredStockMember"
      decimals="0"
      id="Fact000728"
      unitRef="USD">25</rite:ProceedFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-12-31_us-gaap_WarrantMember_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="5"
      id="Fact000730"
      unitRef="Shares">6900000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2024-01-012024-12-31"
      decimals="-6"
      id="Fact000732"
      unitRef="USD">432000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2024-12-31_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-6"
      id="Fact000734"
      unitRef="USD">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000736">&lt;p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zfC0tBIQMK6c" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(2) &lt;span id="xdx_824_zH6z8bl0PZof"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVgQwyyQxuNk" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86B_z6zN7SmXwRMd"&gt;Basis of Presentation&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;)
and the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) applicable to annual reports on Form
10-K.&lt;/p&gt;

&lt;p id="xdx_85D_zgH623WuJ7od" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zkBV2z4T2I9i" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_zef9i38yk3ui"&gt;Use of Estimates&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues
and expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Actual results could differ materially
from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant areas that require the use
of estimates include, but are not limited to:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Asset valuations, including mineral assets and inventory in process,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recoverability assessments,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The fair value of equity-based transactions,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The valuation of liabilities and contingencies,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Derecognition of obligations,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The allocation of purchase price in business combinations, and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The assessment of going concern.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_858_zd2xtvG63Y69" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_z0Qn9jBy5QTa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_868_zXoEONhiusi5"&gt;Principles of Consolidation&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of MineralRite Corporation and all of its wholly owned subsidiaries. All intercompany balances and transactions have
been eliminated upon consolidation in accordance with ASC 810, &lt;i&gt;Consolidation&lt;/i&gt;.&lt;/p&gt;

&lt;p id="xdx_858_zDpH7gRgpOS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--DeferredOfferingCostsPolicyTextBlock_zDsGQPiBtTpc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_864_zActPi7UL7c1"&gt;Deferred Offering Costs&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company capitalizes certain legal,
accounting, and other third-party costs directly associated with ongoing or proposed securities offerings. These costs are classified
as deferred offering costs on the balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Upon successful completion of the offering,
these amounts are offset against the proceeds as a reduction to additional paid-in capital. If an offering is abandoned or withdrawn,
the costs are expensed in the period that determination is made.&lt;/p&gt;

&lt;p id="xdx_858_zMiVkWSi1za5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z62QKMoFprBd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86F_zPQyq1rzKa87"&gt;Cash and Cash Equivalents&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers all highly liquid
investments with original maturities of three months or less to be cash equivalents. The Company maintains its cash in bank deposit
accounts which may, at times, exceed federally insured limits. The Company has not experienced any losses in such accounts.&lt;/p&gt;

&lt;p id="xdx_858_zBfPmLr6Wkz" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zxA6CjqBtJtc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_z7s3bDiyTZ4d"&gt;Concentration of Credit Risk&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially
subject the Company to concentrations of credit risk consist primarily of cash deposits. The Company maintains its cash with financial
institutions that are federally insured. At times, such balances may exceed insured limits. The Company has not experienced any
losses in these accounts.&lt;/p&gt;

&lt;p id="xdx_858_zi7H3Rk6WQof" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zcyyzJSstWqh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_867_zp5esLaiUnrj"&gt;Revenue Recognition&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes revenue in accordance
with ASC 606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;.&#160;Revenue is recognized when control of the promised goods or services
is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those
goods or services.&lt;/p&gt;

&lt;p id="xdx_858_zQQoTZl00hf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zhB1zV1TKAZh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_860_zNXOWcAsrQqa"&gt;Accounts Receivable&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accounts receivable are stated at amounts
due from customers, net of an allowance for credit losses when applicable. The Company evaluates the collectability of receivables
and records an allowance for credit losses based on historical experience, current conditions, and reasonable and supportable forecasts.&lt;/p&gt;

&lt;p id="xdx_858_z3IvUxhKhjFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--InventoryPolicyTextBlock_zmEgOnVwhIjg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86D_zkuBYqDMFWe1"&gt;Inventory&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost
or net realizable value in accordance with ASC 330.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory, when held, consists of finished
or near-finished precious metal products, such as dor&#xe9; bars, bullion, or metals held for matched purchase and sale transactions,
that are intended for sale in the ordinary course of business within a reasonable operating cycle.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Materials requiring substantial processing,
development, or capital expenditure before becoming saleable, including mine tailings and similar materials, are not classified
as inventory and are instead presented as mineral assets or other long-lived assets, as appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs assigned to inventory include purchase
price and other costs directly attributable to bringing finished or near-finished products to their existing condition and location.
Inventory is evaluated at each reporting date and written down to net realizable value when the carrying amount exceeds the amount
expected to be realized.&lt;/p&gt;

&lt;p id="xdx_858_z1B0nSCyJRn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zQprYkpPzwJ9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_zDZU9dP3tg7d"&gt;Property, Plant and Equipment&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property, plant and equipment are stated
at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives
of the related assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Maintenance and repairs are expensed as
incurred. Major improvements that extend the useful life of an asset are capitalized.&lt;/p&gt;

&lt;p id="xdx_858_zdZJ5s15LBSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zWzHuJq0AHj3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_861_zBIzo8h6NGIf"&gt;Mineral Properties and Intangible Assets&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Mineral properties and related intangible
assets are recorded at cost and consist primarily of mineral leases, acquired tailings, and related project-level rights and plans.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates mineral properties
and intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If such indicators are present, the Company
compares the carrying value of the asset to the estimated undiscounted future cash flows expected to result from the use and eventual
disposition of the asset. If the carrying value exceeds those cash flows, an impairment loss is recognized in the amount by which
the carrying value exceeds the estimated fair value.&lt;/p&gt;

&lt;p id="xdx_858_z7TnaEePsk1f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--BusinessCombinationsPolicy_zqc5XVuC2Bl6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_864_zmPABmViID59"&gt;Business Combinations&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for business combinations
in accordance with ASC 805, &lt;i&gt;Business Combinations&lt;/i&gt;. The Company allocates the purchase price of an acquired business to the
assets acquired and liabilities assumed based on their estimated fair values at the acquisition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any excess of the purchase price over the
fair value of the identifiable net assets acquired is recorded as goodwill. Acquisition-related costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For acquisitions that do not meet the definition
of a business, the transaction is accounted for as an asset acquisition, and the cost of the acquisition is allocated to the assets
acquired on a relative fair value basis.&lt;/p&gt;

&lt;p id="xdx_858_z4IjoKvURC1l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zUbmQkzJYiUi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_864_zxRkEPvxcmw2"&gt;Goodwill&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill represents the excess of the purchase
price over the fair value of identifiable net assets acquired in a business combination. Goodwill is not amortized but is tested
for impairment at least annually or more frequently if events or changes in circumstances indicate potential impairment.&lt;/p&gt;

&lt;p id="xdx_858_zmrBbvBFrhxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_zjBxGRzwUnOd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_862_zvM4tQ3kAeUi"&gt;Leases&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for leases in accordance
with ASC 842, &lt;i&gt;Leases&lt;/i&gt;. The Company determines whether an arrangement contains a lease at inception.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Right-of-use assets represent the Company&#x2019;s
right to use an underlying asset during the lease term, and lease liabilities represent the Company&#x2019;s obligation to make
lease payments arising from the lease.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Lease assets and liabilities are recognized
at the commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

&lt;p id="xdx_858_zwyXdMXS24Kl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--DebtPolicyTextBlock_z0gakDVWsh2g" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86B_zBOQV1YkfFi8"&gt;Debt and Notes Payable&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Debt and notes payable are recorded at
the principal amount borrowed, net of any unamortized discounts or premiums. Debt issuance costs, if any, are amortized over the
term of the related debt using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Interest expense is recognized over the
term of the borrowing.&lt;/p&gt;

&lt;p id="xdx_858_zpjvxKXddL26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z6eGdExAuXUa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_862_zwV5gy8Y5SKi"&gt;Fair Value of Financial Instruments&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company follows ASC 820, &lt;i&gt;Fair Value
Measurement&lt;/i&gt;, for financial assets and liabilities measured at fair value on a recurring basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 820 establishes a three-level fair
value hierarchy that prioritizes the inputs used to measure fair value:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2: Observable inputs other than Level 1 quoted prices.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3: Unobservable inputs reflecting the Company&#x2019;s own assumptions.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of cash, accounts
payable, and accrued liabilities approximate fair value due to their short-term nature.&lt;/p&gt;

&lt;p id="xdx_858_zMnvP8dgM8Oi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zh975Yva5T4e" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_zBf9E02jo8Fd"&gt;Stock-Based Compensation&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock-based compensation
in accordance with ASC 718, &lt;i&gt;Compensation&#x2014;Stock Compensation&lt;/i&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Stock-based compensation is measured at
the grant-date fair value of the equity instruments issued and is recognized as compensation expense over the requisite service
period, if any.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If equity instruments are issued for services
and the fair value of the services is more reliably measurable than the fair value of the equity instruments, the Company measures
the transaction based on the fair value of the services received.&lt;/p&gt;

&lt;p id="xdx_858_zKfTONBKuVi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zoobrmyBrr7b" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86A_z39XUnWAQFJj"&gt;Earnings (Loss) per Share&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic earnings (loss) per share is computed
by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during
the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Diluted earnings (loss) per share reflects
the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into
common stock. For periods in which the Company reports a net loss, all potentially dilutive securities are excluded from the calculation
because their effect would be anti-dilutive.&lt;/p&gt;

&lt;p id="xdx_858_zXSqqX8Vpp5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_z5B9rz5r1Df4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86E_zNz23GTrVw34"&gt;Income Taxes&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes in
accordance with ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt;. Deferred tax assets and liabilities are recognized for the expected future tax consequences
of events that have been included in the financial statements or tax returns.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred tax assets and liabilities are
determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using
enacted tax rates expected to apply when those differences are reversed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A valuation allowance is provided when
it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/p&gt;

&lt;p id="xdx_858_zqMEEGnChkX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zCLMwoFBjK14" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86E_zmvJLLN7B0X8"&gt;Segment Reporting&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company operates in a single operating
segment focused on mineral asset acquisition, evaluation, and development. Accordingly, the Company has one reportable segment.&lt;/p&gt;

&lt;p id="xdx_858_zW9o8oInFlT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000738">&lt;p id="xdx_844_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zVgQwyyQxuNk" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86B_z6zN7SmXwRMd"&gt;Basis of Presentation&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial
statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;)
and the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) applicable to annual reports on Form
10-K.&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2025-01-01to2025-12-31" id="Fact000741">&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zkBV2z4T2I9i" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_zef9i38yk3ui"&gt;Use of Estimates&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues
and expenses during the reporting period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Actual results could differ materially
from those estimates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant areas that require the use
of estimates include, but are not limited to:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Asset valuations, including mineral assets and inventory in process,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Recoverability assessments,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The fair value of equity-based transactions,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The valuation of liabilities and contingencies,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Derecognition of obligations,&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The allocation of purchase price in business combinations, and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The assessment of going concern.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000743">&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_z0Qn9jBy5QTa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_868_zXoEONhiusi5"&gt;Principles of Consolidation&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The consolidated financial statements include
the accounts of MineralRite Corporation and all of its wholly owned subsidiaries. All intercompany balances and transactions have
been eliminated upon consolidation in accordance with ASC 810, &lt;i&gt;Consolidation&lt;/i&gt;.&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <rite:DeferredOfferingCostsPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000745">&lt;p id="xdx_84E_ecustom--DeferredOfferingCostsPolicyTextBlock_zDsGQPiBtTpc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_864_zActPi7UL7c1"&gt;Deferred Offering Costs&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company capitalizes certain legal,
accounting, and other third-party costs directly associated with ongoing or proposed securities offerings. These costs are classified
as deferred offering costs on the balance sheet.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Upon successful completion of the offering,
these amounts are offset against the proceeds as a reduction to additional paid-in capital. If an offering is abandoned or withdrawn,
the costs are expensed in the period that determination is made.&lt;/p&gt;

</rite:DeferredOfferingCostsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000747">&lt;p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z62QKMoFprBd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86F_zPQyq1rzKa87"&gt;Cash and Cash Equivalents&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers all highly liquid
investments with original maturities of three months or less to be cash equivalents. The Company maintains its cash in bank deposit
accounts which may, at times, exceed federally insured limits. The Company has not experienced any losses in such accounts.&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-01-01to2025-12-31" id="Fact000749">&lt;p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zxA6CjqBtJtc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_z7s3bDiyTZ4d"&gt;Concentration of Credit Risk&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially
subject the Company to concentrations of credit risk consist primarily of cash deposits. The Company maintains its cash with financial
institutions that are federally insured. At times, such balances may exceed insured limits. The Company has not experienced any
losses in these accounts.&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000752">&lt;p id="xdx_84A_eus-gaap--RevenueRecognitionPolicyTextBlock_zcyyzJSstWqh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_867_zp5esLaiUnrj"&gt;Revenue Recognition&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company recognizes revenue in accordance
with ASC 606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;.&#160;Revenue is recognized when control of the promised goods or services
is transferred to customers in an amount that reflects the consideration the Company expects to receive in exchange for those
goods or services.&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2025-01-01to2025-12-31" id="Fact000754">&lt;p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zhB1zV1TKAZh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_860_zNXOWcAsrQqa"&gt;Accounts Receivable&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accounts receivable are stated at amounts
due from customers, net of an allowance for credit losses when applicable. The Company evaluates the collectability of receivables
and records an allowance for credit losses based on historical experience, current conditions, and reasonable and supportable forecasts.&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000756">&lt;p id="xdx_842_eus-gaap--InventoryPolicyTextBlock_zmEgOnVwhIjg" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86D_zkuBYqDMFWe1"&gt;Inventory&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost
or net realizable value in accordance with ASC 330.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory, when held, consists of finished
or near-finished precious metal products, such as dor&#xe9; bars, bullion, or metals held for matched purchase and sale transactions,
that are intended for sale in the ordinary course of business within a reasonable operating cycle.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Materials requiring substantial processing,
development, or capital expenditure before becoming saleable, including mine tailings and similar materials, are not classified
as inventory and are instead presented as mineral assets or other long-lived assets, as appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs assigned to inventory include purchase
price and other costs directly attributable to bringing finished or near-finished products to their existing condition and location.
Inventory is evaluated at each reporting date and written down to net realizable value when the carrying amount exceeds the amount
expected to be realized.&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000758">&lt;p id="xdx_84F_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zQprYkpPzwJ9" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_zDZU9dP3tg7d"&gt;Property, Plant and Equipment&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property, plant and equipment are stated
at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives
of the related assets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Maintenance and repairs are expensed as
incurred. Major improvements that extend the useful life of an asset are capitalized.&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2025-01-01to2025-12-31" id="Fact000760">&lt;p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zWzHuJq0AHj3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_861_zBIzo8h6NGIf"&gt;Mineral Properties and Intangible Assets&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Mineral properties and related intangible
assets are recorded at cost and consist primarily of mineral leases, acquired tailings, and related project-level rights and plans.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates mineral properties
and intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If such indicators are present, the Company
compares the carrying value of the asset to the estimated undiscounted future cash flows expected to result from the use and eventual
disposition of the asset. If the carrying value exceeds those cash flows, an impairment loss is recognized in the amount by which
the carrying value exceeds the estimated fair value.&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2025-01-01to2025-12-31" id="Fact000763">&lt;p id="xdx_84B_eus-gaap--BusinessCombinationsPolicy_zqc5XVuC2Bl6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_864_zmPABmViID59"&gt;Business Combinations&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for business combinations
in accordance with ASC 805, &lt;i&gt;Business Combinations&lt;/i&gt;. The Company allocates the purchase price of an acquired business to the
assets acquired and liabilities assumed based on their estimated fair values at the acquisition date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Any excess of the purchase price over the
fair value of the identifiable net assets acquired is recorded as goodwill. Acquisition-related costs are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For acquisitions that do not meet the definition
of a business, the transaction is accounted for as an asset acquisition, and the cost of the acquisition is allocated to the assets
acquired on a relative fair value basis.&lt;/p&gt;

</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2025-01-01to2025-12-31" id="Fact000765">&lt;p id="xdx_84C_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zUbmQkzJYiUi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_864_zxRkEPvxcmw2"&gt;Goodwill&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Goodwill represents the excess of the purchase
price over the fair value of identifiable net assets acquired in a business combination. Goodwill is not amortized but is tested
for impairment at least annually or more frequently if events or changes in circumstances indicate potential impairment.&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000767">&lt;p id="xdx_841_eus-gaap--LesseeLeasesPolicyTextBlock_zjBxGRzwUnOd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_862_zvM4tQ3kAeUi"&gt;Leases&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for leases in accordance
with ASC 842, &lt;i&gt;Leases&lt;/i&gt;. The Company determines whether an arrangement contains a lease at inception.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Right-of-use assets represent the Company&#x2019;s
right to use an underlying asset during the lease term, and lease liabilities represent the Company&#x2019;s obligation to make
lease payments arising from the lease.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Lease assets and liabilities are recognized
at the commencement date based on the present value of lease payments over the lease term.&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000769">&lt;p id="xdx_842_eus-gaap--DebtPolicyTextBlock_z0gakDVWsh2g" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86B_zBOQV1YkfFi8"&gt;Debt and Notes Payable&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Debt and notes payable are recorded at
the principal amount borrowed, net of any unamortized discounts or premiums. Debt issuance costs, if any, are amortized over the
term of the related debt using the effective interest method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Interest expense is recognized over the
term of the borrowing.&lt;/p&gt;

</us-gaap:DebtPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-01-01to2025-12-31" id="Fact000771">&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z6eGdExAuXUa" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_862_zwV5gy8Y5SKi"&gt;Fair Value of Financial Instruments&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company follows ASC 820, &lt;i&gt;Fair Value
Measurement&lt;/i&gt;, for financial assets and liabilities measured at fair value on a recurring basis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 820 establishes a three-level fair
value hierarchy that prioritizes the inputs used to measure fair value:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 1: Quoted prices in active markets for identical assets or liabilities.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 2: Observable inputs other than Level 1 quoted prices.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Level 3: Unobservable inputs reflecting the Company&#x2019;s own assumptions.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of cash, accounts
payable, and accrued liabilities approximate fair value due to their short-term nature.&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2025-01-01to2025-12-31" id="Fact000774">&lt;p id="xdx_84C_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zh975Yva5T4e" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_866_zBf9E02jo8Fd"&gt;Stock-Based Compensation&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for stock-based compensation
in accordance with ASC 718, &lt;i&gt;Compensation&#x2014;Stock Compensation&lt;/i&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Stock-based compensation is measured at
the grant-date fair value of the equity instruments issued and is recognized as compensation expense over the requisite service
period, if any.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If equity instruments are issued for services
and the fair value of the services is more reliably measurable than the fair value of the equity instruments, the Company measures
the transaction based on the fair value of the services received.&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000776">&lt;p id="xdx_842_eus-gaap--EarningsPerSharePolicyTextBlock_zoobrmyBrr7b" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86A_z39XUnWAQFJj"&gt;Earnings (Loss) per Share&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic earnings (loss) per share is computed
by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during
the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Diluted earnings (loss) per share reflects
the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into
common stock. For periods in which the Company reports a net loss, all potentially dilutive securities are excluded from the calculation
because their effect would be anti-dilutive.&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000778">&lt;p id="xdx_848_eus-gaap--IncomeTaxPolicyTextBlock_z5B9rz5r1Df4" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86E_zNz23GTrVw34"&gt;Income Taxes&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes in
accordance with ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt;. Deferred tax assets and liabilities are recognized for the expected future tax consequences
of events that have been included in the financial statements or tax returns.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Deferred tax assets and liabilities are
determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using
enacted tax rates expected to apply when those differences are reversed.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A valuation allowance is provided when
it is more likely than not that some portion or all of the deferred tax assets will not be realized.&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000781">&lt;p id="xdx_841_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zCLMwoFBjK14" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_86E_zmvJLLN7B0X8"&gt;Segment Reporting&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company operates in a single operating
segment focused on mineral asset acquisition, evaluation, and development. Accordingly, the Company has one reportable segment.&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000783">&lt;p id="xdx_803_eus-gaap--NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_zLJNN03YK9O8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(3) &lt;span id="xdx_82C_zxNOMU7hPmi9"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company regularly monitors and evaluates
new accounting standards issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In November 2023, the FASB issued ASU 2023-07,
&lt;i&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/i&gt;, which expands disclosure requirements for
reportable segments. The amendments are effective for fiscal years beginning after December 15, 2023. The Company is currently
evaluating the impact of this standard on its consolidated financial statement disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2023, the FASB issued ASU 2023-09,
&lt;i&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/i&gt;, which requires enhanced disclosures related to income
taxes. The amendments are effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the
impact of this standard.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Other than the standards described above,
management does not believe that any recently issued, but not yet effective, accounting pronouncements would have a material impact
on the Company&#x2019;s consolidated financial position, results of operations, or cash flows.&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000785">&lt;p id="xdx_80F_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_z9RCUlxgSmig" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(4) &lt;span id="xdx_82E_z7rEags9kRa7"&gt;Going Concern Considerations&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying consolidated financial
statements have been prepared assuming that the Company will continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has not yet generated significant
revenues from its principal operations and has incurred operating losses as it advances its mineral asset projects. Management
has historically funded operations through the issuance of equity securities, debt arrangements, and related financing activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with ASC 205-40, management
is required to evaluate, and has evaluated, whether there are conditions or events that raise substantial doubt about the Company&#x2019;s
ability to continue as a going concern for a period of one year from the date the financial statements are issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management&#x2019;s plans include raising
additional capital through equity or debt financings, advancing its mineral asset projects toward revenue-generating operations,
and pursuing strategic transactions or asset-level financings. The Company has historically been successful in obtaining capital
to support its operations. Management believes these plans are probable of being effectively implemented and are expected to mitigate
any such conditions or events.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These conditions raise substantial doubt
about the Company&#x2019;s ability to continue as a going concern. Management&#x2019;s plans to address these conditions include
raising capital through equity or debt financings, entering into strategic partnerships or joint ventures, and monetizing mineral
assets or related opportunities. The accompanying consolidated financial statements have been prepared assuming the Company will
continue as a going concern, and do not include any adjustments that might result from the outcome of this uncertainty. However,
there can be no assurance that future financing will be available on acceptable terms or at all.&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000788">&lt;p id="xdx_805_eus-gaap--BusinessCombinationDisclosureTextBlock_zJzaCz72PiOf" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(5) &lt;span id="xdx_823_zNR06NMVqwIh"&gt;Business Combinations&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 31, 2024, the Company completed
the acquisition of California Precious Metals LLC (&#x201c;CPM&#x201d;) and Peeples, Inc. (&#x201c;Peeples&#x201d;) pursuant to a transaction
with NMC. The results of these acquisitions are reflected in the Company&#x2019;s consolidated financial statements as of the acquisition
date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Peeples, Inc.&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The acquisition of Peeples was determined
to constitute a business under ASC 805, &lt;i&gt;Business Combinations&lt;/i&gt;, and was accounted for as a business combination. Peeples
held previously processed mine tailings classified as chattel (personal property), a written mine development plan, technical documentation,
and strategic relationships necessary to advance operations. These materials were not unprocessed in-situ mineral resources, but
rather previously processed tailings that functioned economically as inventory-type material supported by technical and metallurgical
data.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;California Precious Metals LLC&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The acquisition of CPM was treated as an
asset acquisition, as the acquired set of assets did not meet the definition of a business under ASC 805. CPM held mineral leases
and related rights without supporting infrastructure, workforce, or business activity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Consideration and Allocation&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The total consideration for the transaction
was approximately $&lt;span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferredOther1_pn6n6_c20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--PeeplesMember_zWgTr9NgMlI1" title="Business consideration amount"&gt;432&lt;/span&gt; million, consisting primarily of the issuance of &lt;span id="xdx_90C_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pn5n6_uShares_c20240101__20241231__us-gaap--BusinessAcquisitionAxis__custom--SeriesNMCPreferredStockMember_zylP2wgNuo9k" title="Business Acquisition, Equity Interest Issued or Issuable, Number of Shares"&gt;6.9&lt;/span&gt; million shares of Series NMC $&lt;span id="xdx_90A_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_uUSDPShares_c20241231_zlaQnF9OZFob" title="Preferred Stock, Convertible, Conversion Price"&gt;25&lt;/span&gt; Convertible Preferred
Stock and &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pn5n6_uShares_c20241231__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_zLsloLkBTp01" title="Class of Warrant or Right, Number of Securities Called by Warrants or Rights"&gt;6.9&lt;/span&gt; million warrants to purchase the same. The Company also assumed approximately $&lt;span id="xdx_900_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_iI_pn6n6_uUSD_c20241231__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_z0UUYavQsIUb" title="Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities"&gt;5&lt;/span&gt; million of liabilities associated
with the acquired entities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series NMC Convertible Preferred Stock
included a structured sinking fund repurchase feature providing for a minimum repurchase price of $&lt;span id="xdx_905_eus-gaap--PreferredStockRedemptionPricePerShare_iI_pid_uUSDPShares_c20241231__us-gaap--BusinessAcquisitionAxis__custom--SeriesNMCPreferredStockMember_zexZiOa8kgM6" title="Preferred Stock, Convertible, Conversion Price"&gt;25.40&lt;/span&gt; per share, which accretes
at a rate of &lt;span id="xdx_90D_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uRatio_c20240101__20241231_z4kbta0Qrz64" title="Preferred Stock, Dividend Rate, Percentage"&gt;5&lt;/span&gt;% per year. This feature was considered in determining the fair value of the securities issued.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the consideration transferred
was determined based on the fair value of the securities issued, consistent with ASC 805. Management determined that the fair value
of the consideration transferred approximated the fair value of the net assets acquired based on the valuation analyses performed
in connection with the transaction.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company allocated the consideration
among the acquired assets and assumed liabilities based on their estimated fair values at the acquisition date. Substantially all
of the assigned value was attributed to the previously processed mine tailings classified as chattel (personal property) acquired
in the Peeples transaction. The two mineral leases held by California Precious Metals and the approximately 377.11-acre Arizona
State Land Department lease held by Peeples were recorded at their allocated fair values based on management&#x2019;s analysis.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These valuations were not based on proven
or probable reserves, but rather reflected strategic value, development potential, technical data, and related intellectual property
associated with the acquired materials.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;No goodwill was recognized in connection
with these acquisitions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The resulting assets and liabilities acquired
form a significant portion of the Company&#x2019;s consolidated balance sheet as of December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acquisition-related costs were expensed
as incurred.&lt;/p&gt;

</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferredOther1
      contextRef="From2024-01-012024-12-31_custom_PeeplesMember"
      decimals="-6"
      id="Fact000790"
      unitRef="USD">432000000</us-gaap:BusinessCombinationConsiderationTransferredOther1>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2024-01-012024-12-31_custom_SeriesNMCPreferredStockMember212184531"
      decimals="-5"
      id="Fact000792"
      unitRef="Shares">6900000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000794"
      unitRef="USDPShares">25</us-gaap:PreferredStockConvertibleConversionPrice>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-12-31_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-5"
      id="Fact000796"
      unitRef="Shares">6900000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="AsOf2024-12-31_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="-6"
      id="Fact000798"
      unitRef="USD">5000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:PreferredStockRedemptionPricePerShare
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember212184531"
      decimals="INF"
      id="Fact000800"
      unitRef="USDPShares">25.40</us-gaap:PreferredStockRedemptionPricePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact000802"
      unitRef="Ratio">0.05</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000805">&lt;p id="xdx_804_eus-gaap--RevenueFromContractWithCustomerTextBlock_zfD5JxxU81Q" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(6) &lt;span id="xdx_82A_zYdSGtrdhjR2"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has not recognized revenue
from its principal operations during the reporting period. Revenue recognition policies are established in accordance with ASC
606, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company expects to generate future
revenue through the sale of minerals and the matched purchase and sale transactions involving precious metals. Revenue will be
recognized when control of the product or service is transferred to the customer, in an amount that reflects the consideration
to which the Company expects to be entitled in exchange for those goods or services. Revenue is expected to be recognized at a
point in time when control transfers, typically upon delivery or transfer of title, depending on the terms of the underlying agreements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;No disaggregated revenue disclosures are
presented since the Company did not generate revenue from its principal operations during the reporting period.&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:AccountsAndNontradeReceivableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000807">&lt;p id="xdx_805_eus-gaap--AccountsAndNontradeReceivableTextBlock_zpEbQEU0yA5a" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(7) &lt;span id="xdx_825_zqBCGNKc45D1"&gt;Accounts Receivable / Credit Losses&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, and 2024, the
Company had no material accounts receivable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has adopted the provisions
of ASC 326, &lt;i&gt;Financial Instruments&#x2014;Credit Losses&lt;/i&gt;, and will apply the current expected credit loss (&#x201c;CECL&#x201d;)
model to future accounts receivable as they arise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When accounts receivable are recorded,
an allowance for credit losses will be established based on historical experience, current economic conditions, and reasonable
forecasts.&lt;/p&gt;

</us-gaap:AccountsAndNontradeReceivableTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000810">&lt;p id="xdx_806_eus-gaap--InventoryDisclosureTextBlock_zv3xkSFaTa1f" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(8) &lt;span id="xdx_825_zp2Ps9JOVAA5"&gt;Inventory&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost
or net realizable value in accordance with ASC 330.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Inventory, when held, consists of finished
or near-finished precious metal products, such as dor&#xe9; bars, bullion, or metals held for matched purchase and sale transactions,
that are intended for sale in the ordinary course of business within a reasonable operating cycle.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Materials requiring substantial processing,
development, or capital expenditure before becoming saleable, including mine tailings and similar materials, are not classified
as inventory and are instead presented as mineral assets or other long-lived assets, as appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, and 2024, the
Company did not report any inventory on its consolidated balance sheets.&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000812">&lt;p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zZ9Ewmx7w1rj" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(9) &lt;span id="xdx_823_zuz1Weqn4Q1l"&gt;Property, Plant and Equipment&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Property and equipment are recorded at
historical cost. Major additions and improvements that extend the useful life or functionality of an asset are capitalized, while
routine repairs and maintenance are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Depreciation and Depletion&#160;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_zjOm4yZCfMEb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation is calculated using the straight-line
method over the estimated useful lives of the related assets as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zGlA3O5dc1T9" style="display: none; visibility: hidden"&gt;Schedule Of Property Plant And Equipment Depreciation&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="width: 69%; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Asset Category&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 31%; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Office and computer equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQrtBUcRNTo4"&gt;3&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI3cX0zTnY39"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Machinery and processing equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zmaXVffEy7qc"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zx6NXr4bFAPh"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AF_zBsG6ujJPeQh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For assets associated with mineral recovery
operations, the Company capitalizes costs that are directly attributable to acquiring, constructing, and placing the asset into
service in accordance with GAAP. When depletion is applicable to resource-based assets, the Company uses the unit-of-production
method to allocate the capitalized cost over the volume of resource extracted during the reporting period. No depletion expense
has been recorded to date due to the absence of production.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Impairment of Long-Lived Assets&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company reviews long-lived assets,
including property and equipment, for impairment whenever events or changes in circumstances indicate that the carrying amount
of an asset may not be recoverable. Recoverability is assessed based on the estimated undiscounted future cash flows expected to
result from the use of the asset. If the carrying value exceeds those cash flows, an impairment loss is recognized equal to the
difference between the asset&#x2019;s carrying amount and its estimated fair value in accordance with ASC 360, &lt;i&gt;Property, Plant,
and Equipment&lt;/i&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;No depreciation or impairment expense was
recorded during the periods presented, as the Company&#x2019;s equipment remained in storage and was not placed into service during
those periods.&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000814">&lt;p id="xdx_89A_eus-gaap--ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock_zjOm4yZCfMEb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Depreciation is calculated using the straight-line
method over the estimated useful lives of the related assets as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B9_zGlA3O5dc1T9" style="display: none; visibility: hidden"&gt;Schedule Of Property Plant And Equipment Depreciation&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 50%; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="width: 69%; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Asset Category&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 31%; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Estimated Useful Life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Office and computer equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zQrtBUcRNTo4"&gt;3&lt;/span&gt; &#x2013; &lt;span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zI3cX0zTnY39"&gt;7&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Machinery and processing equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MinimumMember_zmaXVffEy7qc"&gt;5&lt;/span&gt; &#x2013; &lt;span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20251231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember__srt--RangeAxis__srt--MaximumMember_zx6NXr4bFAPh"&gt;10&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfPublicUtilityPropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-12-31_us-gaap_ComputerEquipmentMember_srt_MinimumMember"
      id="Fact000815">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-12-31_us-gaap_ComputerEquipmentMember_srt_MaximumMember"
      id="Fact000816">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-12-31_us-gaap_MachineryAndEquipmentMember_srt_MinimumMember"
      id="Fact000817">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-12-31_us-gaap_MachineryAndEquipmentMember_srt_MaximumMember"
      id="Fact000818">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000821">&lt;p id="xdx_801_eus-gaap--GoodwillAndIntangibleAssetsDisclosureTextBlock_zqdFXaNHoIIc" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(10) &lt;span id="xdx_822_zM6YdKUwZm2c"&gt;Mineral Properties / Intangible Assets / Goodwill&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Accounting Policy&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Mineral properties are classified as either
tangible or intangible assets depending on the nature of the rights acquired:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Mineral Rights (Intangible Assets):&lt;/b&gt; Rights to explore or extract minerals from specific
properties.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Mine Development and Infrastructure (Tangible Assets):&lt;/b&gt; Includes stripping, drilling, road
access, tailings-related infrastructure, and other capitalized site-development activities.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company capitalizes acquisition costs,
including legal and other directly attributable expenses, when control of a mineral interest is obtained.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Exploration and evaluation expenditures
are capitalized when they relate to specific mineral properties and management concludes that future economic benefits are probable.
Regional or preliminary exploration expenditures not directly attributable to a specific property are expensed as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Development expenditures are capitalized
once technical feasibility and commercial viability are demonstrable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All mineral properties currently held by
the Company are not yet in commercial production. Accordingly, no depletion, depreciation, or amortization has been recorded. Once
production begins, tangible mineral property costs will be depreciated using the units-of-production method, and intangible mineral
rights will be amortized over the estimated reserve life or evaluated for impairment if not yet placed in service.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Carrying Value and Impairment&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates its mineral properties
for impairment indicators in accordance with ASC 360-10, &lt;i&gt;Property, Plant, and Equipment&lt;/i&gt;. Assets are written down to fair
value if events or changes in circumstances indicate that their carrying amount may not be recoverable. As of the reporting date,
no such indicators have been identified.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Standalone mineral leases for which no
separate consideration was paid and for which no independently measurable fair value is available are carried at a value of $0.
These leases represent enabling legal rights associated with the underlying mineral assets and are evaluated as part of the related
asset group for impairment purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Business Combinations and Fair Value Allocation&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Mineral interests acquired in a business
combination are recorded at fair value as of the acquisition date in accordance with ASC 805. Fair value is determined using market-participant
assumptions and appropriate valuation techniques consistent with ASC 820.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On December 31, 2024, the Company acquired
California Precious Metals LLC and Peeples Inc., which together held three mineral properties and previously processed mine tailings.
The Peeples acquisition was accounted for as a business combination.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The acquired set included:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Previously processed mine tailings;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;A mineral lease providing site access;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;A written mine development plan;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Technical, metallurgical, and environmental datasets; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Associated project documentation and operational relationships.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These elements were evaluated collectively
in determining the acquisition-date fair value of the identifiable net assets acquired and the appropriate accounting treatment
under ASC 805, as described in the Company&#x2019;s Form 10 and related correspondence with the SEC Staff.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Based on the acquisition-date fair value
of the consideration transferred, the Company recorded identifiable net assets of approximately $&lt;span id="xdx_902_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_uUSD_c20251231_zvrs8ijmntIf" title="Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net"&gt;432,000,000&lt;/span&gt;. No goodwill was recognized.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Net Assets Acquired&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--MineralAssetsAcquisationTableTextBlock_zRGCsLH6PAQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8BA_zdVR3jfwtHei" style="display: none; visibility: hidden"&gt;Schedule of Acquisition of Mineral Assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; width: 70%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Assets and Liabilities Recognized&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Gross&#160;Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Accumulated Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Peeples, Inc - Previously processed mine tailings, including associated mineral lease, mine plan, permitting, and technical documentation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--MineTailingsAndPermittingServicesMember_zDhgZJktEP3l" style="text-align: center" title="Mine tailings (inventory-in-process) including mineral lease, mine plan, permitting and technical documentation"&gt;&lt;span style="font-size: 10pt"&gt;$432,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--MineTailingsAndPermittingServicesMember_zW9gRGYuvtw" style="text-align: center" title="Mine tailings (inventory-in-process) including mineral lease, mine plan, permitting and technical documentation"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--MineTailingsAndPermittingServicesMember_zsK5lufuLl9i" style="text-align: center" title="Mine tailings (inventory-in-process) including mineral lease, mine plan, permitting and technical documentation"&gt;&lt;span style="font-size: 10pt"&gt;$432,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Peeples, Inc. &#x2013; mineral lease (377.11 acres)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--PeeplesMineralLeaseMember_zS7fJuYSv0Mi" style="text-align: center" title="Peeples - Mineral lease comprising 377.11 acres (all value assigned to inventory-in-process)"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--PeeplesMineralLeaseMember_zKD4wdR3knBf" style="text-align: center" title="Peeples - Mineral lease comprising 377.11 acres (all value assigned to inventory-in-process)"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--PeeplesMineralLeaseMember_zstcIiFPTkR7" style="text-align: center" title="Peeples - Mineral lease comprising 377.11 acres (all value assigned to inventory-in-process)"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;California Precious Metals LLC &#x2013; exploratory leases&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--CaliforniaPreciousMetalsMember_zfjW9NR3ahH5" style="text-align: center" title="California Precious Metals - BLM Mineral leases"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--CaliforniaPreciousMetalsMember_zW8ZWHTHOKj" style="text-align: center" title="California Precious Metals - BLM Mineral leases"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--CaliforniaPreciousMetalsMember_zZrnqcorD5d4" style="text-align: center" title="California Precious Metals - BLM Mineral leases"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--GoodwillsMember_zdvi63K202Hj" style="text-align: center" title="Goodwill"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--GoodwillsMember_zGcn0omXNZb6" style="text-align: center" title="Goodwill"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--GoodwillsMember_zWFASYuLsMLf" style="text-align: center" title="Goodwill"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--MineralPropertiesGross_iI_dxH_c20251231_zTiMXMJWrQm3" style="text-align: center" title="Gross Carrying Amount::XDX::432011500"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$432,000,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_dxL_c20251231_zKFDOpizPbP5" style="text-align: center" title="Accumulated Depreciation::XDX::%97"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$0&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--MineralPropertiesNet_iI_c20251231_zvGEBWJSCez3" style="text-align: center" title="Net Carrying Amount"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$432,000,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AD_zWvmYa0UpuZe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The table above reflects the acquisition-date
fair value assigned to the mineral assets acquired through the business combination under ASC 805. The tailings asset is supported
by a substantial body of historical engineering, metallurgical, and technical data.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the current period, the Company
engaged an independent Qualified Person to conduct a multi-phase technical evaluation of the Skull Valley tailings as an initial
step toward potential future technical reporting under Regulation S-K Subpart 1300. The Company cannot predict the timing or outcome
of this evaluation, and there is no assurance that any mineral resources or reserves will be established under S-K 1300 standards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of the reporting date, the properties
remain under evaluation, and no indicators of impairment have been identified. No depletion or amortization has been recorded.&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000824"
      unitRef="USD">432000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <rite:MineralAssetsAcquisationTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000826">&lt;p id="xdx_898_ecustom--MineralAssetsAcquisationTableTextBlock_zRGCsLH6PAQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8BA_zdVR3jfwtHei" style="display: none; visibility: hidden"&gt;Schedule of Acquisition of Mineral Assets&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify; width: 70%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Assets and Liabilities Recognized&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Gross&#160;Carrying Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Accumulated Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-size: 10pt"&gt;Peeples, Inc - Previously processed mine tailings, including associated mineral lease, mine plan, permitting, and technical documentation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--MineTailingsAndPermittingServicesMember_zDhgZJktEP3l" style="text-align: center" title="Mine tailings (inventory-in-process) including mineral lease, mine plan, permitting and technical documentation"&gt;&lt;span style="font-size: 10pt"&gt;$432,000,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--MineTailingsAndPermittingServicesMember_zW9gRGYuvtw" style="text-align: center" title="Mine tailings (inventory-in-process) including mineral lease, mine plan, permitting and technical documentation"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--MineTailingsAndPermittingServicesMember_zsK5lufuLl9i" style="text-align: center" title="Mine tailings (inventory-in-process) including mineral lease, mine plan, permitting and technical documentation"&gt;&lt;span style="font-size: 10pt"&gt;$432,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Peeples, Inc. &#x2013; mineral lease (377.11 acres)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--PeeplesMineralLeaseMember_zS7fJuYSv0Mi" style="text-align: center" title="Peeples - Mineral lease comprising 377.11 acres (all value assigned to inventory-in-process)"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--PeeplesMineralLeaseMember_zKD4wdR3knBf" style="text-align: center" title="Peeples - Mineral lease comprising 377.11 acres (all value assigned to inventory-in-process)"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--PeeplesMineralLeaseMember_zstcIiFPTkR7" style="text-align: center" title="Peeples - Mineral lease comprising 377.11 acres (all value assigned to inventory-in-process)"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;California Precious Metals LLC &#x2013; exploratory leases&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--CaliforniaPreciousMetalsMember_zfjW9NR3ahH5" style="text-align: center" title="California Precious Metals - BLM Mineral leases"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--CaliforniaPreciousMetalsMember_zW8ZWHTHOKj" style="text-align: center" title="California Precious Metals - BLM Mineral leases"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--CaliforniaPreciousMetalsMember_zZrnqcorD5d4" style="text-align: center" title="California Precious Metals - BLM Mineral leases"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--MineralPropertiesGross_iI_c20251231__srt--ProductOrServiceAxis__custom--GoodwillsMember_zdvi63K202Hj" style="text-align: center" title="Goodwill"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_c20251231__srt--ProductOrServiceAxis__custom--GoodwillsMember_zGcn0omXNZb6" style="text-align: center" title="Goodwill"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--MineralPropertiesNet_iI_c20251231__srt--ProductOrServiceAxis__custom--GoodwillsMember_zWFASYuLsMLf" style="text-align: center" title="Goodwill"&gt;&lt;span style="font-size: 10pt"&gt;$0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--MineralPropertiesGross_iI_dxH_c20251231_zTiMXMJWrQm3" style="text-align: center" title="Gross Carrying Amount::XDX::432011500"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$432,000,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--MineralPropertiesAccumulatedDepletion_iI_dxL_c20251231_zKFDOpizPbP5" style="text-align: center" title="Accumulated Depreciation::XDX::%97"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0854"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$0&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--MineralPropertiesNet_iI_c20251231_zvGEBWJSCez3" style="text-align: center" title="Net Carrying Amount"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$432,000,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</rite:MineralAssetsAcquisationTableTextBlock>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2025-12-31_custom_MineTailingsAndPermittingServicesMember"
      decimals="0"
      id="Fact000828"
      unitRef="USD">432000000</us-gaap:MineralPropertiesGross>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2025-12-31_custom_MineTailingsAndPermittingServicesMember"
      decimals="0"
      id="Fact000830"
      unitRef="USD">0</us-gaap:MineralPropertiesAccumulatedDepletion>
    <us-gaap:MineralPropertiesNet
      contextRef="AsOf2025-12-31_custom_MineTailingsAndPermittingServicesMember"
      decimals="0"
      id="Fact000832"
      unitRef="USD">432000000</us-gaap:MineralPropertiesNet>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2025-12-31_custom_PeeplesMineralLeaseMember"
      decimals="0"
      id="Fact000834"
      unitRef="USD">0</us-gaap:MineralPropertiesGross>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2025-12-31_custom_PeeplesMineralLeaseMember"
      decimals="0"
      id="Fact000836"
      unitRef="USD">0</us-gaap:MineralPropertiesAccumulatedDepletion>
    <us-gaap:MineralPropertiesNet
      contextRef="AsOf2025-12-31_custom_PeeplesMineralLeaseMember"
      decimals="0"
      id="Fact000838"
      unitRef="USD">0</us-gaap:MineralPropertiesNet>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2025-12-31_custom_CaliforniaPreciousMetalsMember"
      decimals="0"
      id="Fact000840"
      unitRef="USD">0</us-gaap:MineralPropertiesGross>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2025-12-31_custom_CaliforniaPreciousMetalsMember"
      decimals="0"
      id="Fact000842"
      unitRef="USD">0</us-gaap:MineralPropertiesAccumulatedDepletion>
    <us-gaap:MineralPropertiesNet
      contextRef="AsOf2025-12-31_custom_CaliforniaPreciousMetalsMember"
      decimals="0"
      id="Fact000844"
      unitRef="USD">0</us-gaap:MineralPropertiesNet>
    <us-gaap:MineralPropertiesGross
      contextRef="AsOf2025-12-31_custom_GoodwillsMember"
      decimals="0"
      id="Fact000846"
      unitRef="USD">0</us-gaap:MineralPropertiesGross>
    <us-gaap:MineralPropertiesAccumulatedDepletion
      contextRef="AsOf2025-12-31_custom_GoodwillsMember"
      decimals="0"
      id="Fact000848"
      unitRef="USD">0</us-gaap:MineralPropertiesAccumulatedDepletion>
    <us-gaap:MineralPropertiesNet
      contextRef="AsOf2025-12-31_custom_GoodwillsMember"
      decimals="0"
      id="Fact000850"
      unitRef="USD">0</us-gaap:MineralPropertiesNet>
    <us-gaap:MineralPropertiesNet
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000856"
      unitRef="USD">432000000</us-gaap:MineralPropertiesNet>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000859">&lt;p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zvo79WrTQiw7" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(11) &lt;span id="xdx_825_zEEzDMZbIx1i"&gt;Leases&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of the reporting date, the Company
maintains two categories of lease arrangements:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Operating leases, which are accounted for under ASC 842, &lt;i&gt;Leases&lt;/i&gt;; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Mineral leases, which provide rights to explore or develop mineral properties and are accounted
for in accordance with ASC 930, &lt;i&gt;Extractive Activities &#x2013; Mining&lt;/i&gt;, and ASC 360, &lt;i&gt;Property, Plant, and Equipment&lt;/i&gt;.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accounting treatment depends on the
nature and purpose of the lease, as described below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Operating Leases&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has entered into short-term,
low-value lease arrangements for shared office and miscellaneous space. These arrangements qualify for the short-term lease exemption
under ASC 842 and are not recorded on the balance sheet. Lease payments are recognized as expense over the lease term.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of the reporting date, the Company does
not maintain any finance leases or long-term operating leases that require recognition of right-of-use (&#x201c;ROU&#x201d;) assets
or lease liabilities under ASC 842.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Mineral Leases&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company holds certain mineral lease
agreements through its wholly owned subsidiaries that provide rights to explore and potentially develop mineral properties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Annual lease payments, minimum annual guarantee
payments, and related insurance costs are recognized as expense as incurred.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Costs directly attributable to evaluating
or advancing a specific mineral property, such as engineering studies, surveys, and other site-specific technical work, are capitalized
as part of the related mineral asset in accordance with ASC 930 and ASC 360.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of the reporting date, no right-of-use
assets or lease liabilities have been recognized under ASC 842 with respect to mineral leases, as these arrangements represent
mineral property interests accounted for under the extractive activities model rather than operating or financing leases.&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000861">&lt;p id="xdx_802_eus-gaap--DebtDisclosureTextBlock_zespXC5g8pd3" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(12) &lt;span id="xdx_82F_zQii2fgiRJj6"&gt;Debt / Notes Payable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company previously had four promissory
notes outstanding with an aggregate principal balance of $&lt;span id="xdx_90D_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20250101__20251231_zKFmP27hDQz7"&gt;117,500&lt;/span&gt;, all of which were issued between 2012 and 2021 by prior management
to unaffiliated third parties. For an extended period, the Company had not made payments on these instruments and had not received
demands for payment or other communications from the noteholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management evaluated the status of these
obligations under applicable statutes of limitation governing enforcement of debt instruments and, based on that evaluation and
consultation with legal counsel, concluded that claims for repayment are time-barred and not enforceable. In reaching this conclusion,
management considered, among other factors, the absence of creditor activity for many years and the absence of tolling agreements,
waivers, acknowledgments, or other events that would extend or revive the applicable limitations period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Accordingly, during the third quarter of
2025, the Company derecognized the full aggregate principal balance of these obligations pursuant to ASC 405-20-40-1(b). The corresponding
gain on extinguishment was recognized in other income during the year ended December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company continues to monitor communications
and claims, if any, relating to historical obligations.&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000862"
      unitRef="USD">117500</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000864">&lt;p id="xdx_80F_eus-gaap--IncomeTaxDisclosureTextBlock_zwbfzMcmROvi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(13) &lt;span id="xdx_82A_zhfFsIohGT6l"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes in
accordance with ASC 740, &lt;i&gt;Income Taxes&lt;/i&gt;, using the asset and liability method. Deferred tax assets and liabilities are recognized
for the expected future tax consequences of temporary differences between the financial statement and tax bases of assets and liabilities
using enacted tax rates in effect for the years in which those differences are expected to reverse.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During 2024, the Company filed delinquent
federal income tax returns covering prior tax years. Based on those filings, the Company reported net operating loss carryforwards
(&#x201c;NOLs&#x201d;) of approximately $&lt;span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_uUSD_c20251231_zk1IZSzt5Fx1" title="Operating Loss Carryforwards"&gt;8.7&lt;/span&gt; million for federal income tax purposes. These filings remain subject to examination
by the Internal Revenue Service, and no confirmation of the reported NOL amounts has been received.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under ASC 740, tax benefits are recognized
only when it is more likely than not that the position will be sustained upon examination by taxing authorities. Due to the uncertainty
surrounding the ultimate acceptance of the reported NOL amounts, the Company has not recognized a deferred tax asset related to
these reported carryforwards as of December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the years ended December 31, 2025,
and 2024, the Company did not record a current or deferred income tax expense or benefit.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company will continue to evaluate its
tax positions and will recognize any deferred tax assets when the recognition threshold under ASC 740 is met.&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-12-31"
      decimals="-5"
      id="Fact000866"
      unitRef="USD">8700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000868">&lt;p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zc3eto9ARBFk" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(14) &lt;span id="xdx_821_zdLXSW8fYCkj"&gt;Equity / Capital Stock / Earnings per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Capital Structure&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s authorized capital
stock consists of:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;20,000,000,000 shares of common stock, no par value;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;105,000 shares of Series A Preferred Stock, no par value;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;33,000 shares of Series B Preferred Stock, no par value;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;100,000 shares of Series C Preferred Stock, no par value;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;35,000 shares of Series D Preferred Stock, $25 par value;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;7,100,000 shares of Series NMC Preferred Stock, $25 par value; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;42,627,000 shares of undesignated preferred stock, no par value.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_z3xQ15mB8uqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, and December 31,
2024, the following classes and series of capital stock were authorized and issued and outstanding. The table below also summarizes
the par value, voting rights, and conversion terms applicable to each class and series.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_zS7SfjeGFvZf" style="display: none; visibility: hidden"&gt;Schedule of stockholders equity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Par &lt;br/&gt;
Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Authorized&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;br/&gt;
 12/31/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Outstanding &lt;br/&gt;
12/31/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Votes Per &lt;br/&gt;
Share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Conversion &lt;br/&gt;
Ratio&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Common&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231_zcUmwlUqF7Qb" title="Par Value"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20251231_zO7uevHnCx28" title="Authorized Shares"&gt;20,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20251231_zufv6cN1x4dc" title="Outstanding Shares"&gt;6,211,776,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20241231_z0nG4vCpLDwh" title="Outstanding Shares"&gt;4,347,776,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--CommonStockVotingRights_c20250101__20251231_zufSsirmqzz3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Voting Rights"&gt;&lt;span style="font-size: 10pt"&gt;1 vote per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbgbg19aRyad"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zJXxhJ2ccxO3"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLipodDEH3xc"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zT7XDYd5w7y"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdZIjnkF9zyb"&gt;3,000 votes per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series B&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zIg6B9OpPSSl"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdh5tOREKx9g"&gt;33,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbVgsB45Mcqe"&gt;13,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfxtqRGpYVx"&gt;13,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFyuCxUmN9Kd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1,000 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zw8S1xblBd9j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Conversion terms"&gt;&lt;span style="font-size: 10pt"&gt;1 : 1,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zDhZ1xH0pa8e"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zJPy5R6GeBzb"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zFHieWEZSrCk"&gt;9,404&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zGrtPHQJHit6"&gt;8,249&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zvpHDn2aHJF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;400,000 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zMHTFmxfMBBj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1 : 400,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zQlQczK3VCdj"&gt;25&lt;/span&gt; par &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zacqo98rW1J2"&gt;35,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_ztMVTPjlQytk"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_z9jrfOBwSkD9"&gt;700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zHTzZAPJIRHb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;25,000 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zB401VmhTjY9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1 : 25,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series NMC&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zbvIXV7N97Ej"&gt;25&lt;/span&gt; par &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zfUT1utelL2k"&gt;7,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_za5szClHNTj"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zEqPj1HZrD22"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_z6goMfYxFm95" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;500 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zssxBgxNFlJd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1 : 500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Undesignated Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_z6Ot40d5Ctj6"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zLmszU33ZCI4"&gt;42,627,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zrxb2vUJZod1"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_ziVK626DToEg"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AA_zoKpGTtI8r0j" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Common Stock&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Each share of common stock entitles the
holder to one vote on all matters submitted to shareholders. Holders of common stock are entitled to receive dividends when and
if declared by the Board of Directors, subject to any preferential rights of outstanding preferred stock. In the event of liquidation,
holders of common stock are entitled to share ratably in the Company&#x2019;s assets remaining after payment of liabilities and
satisfaction of any preferential rights of preferred stockholders. As of December 31, 2025, and December 31, 2024, there were &lt;span id="xdx_900_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20251231_z9P56RuTXkR1" title="Common Stock, Shares, Issued"&gt;&lt;span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20251231_z37T3ha0Dz84" title="Common Stock, Shares, Outstanding"&gt;6,211,776,842&lt;/span&gt;&lt;/span&gt;
and &lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20241231_zKOLM6U8MTvk" title="Common Stock, Shares, Outstanding"&gt;&lt;span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20241231_ztJ7PuC0Mu4l" title="Common Stock, Shares, Issued"&gt;4,347,776,842&lt;/span&gt;&lt;/span&gt; shares of common stock issued and outstanding, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Preferred Stock&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series A Preferred Stock&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series A Preferred Stock is non-convertible
and entitles the holder to 3,000 votes per share on all matters submitted to shareholders. The Series A Preferred Stock does not
carry dividend rights or liquidation preferences separate from common stock unless otherwise provided in its certificate of designation.
As of December 31, 2025, and December 31, 2024, there were &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLLdBuB5508j" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0fMvNz4nrw5" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_znUD9e0DZ6n6" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zDw2hmqILEd9" title="Preferred Stock, Shares Outstanding"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series A Preferred Stock issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series B Preferred Stock&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Each share of Series B Preferred Stock
is convertible into 1,000 shares of common stock. Each share carries 1,000 votes per share on matters submitted to shareholders.
The Series B Preferred Stock does not have a mandatory redemption feature. As of December 31, 2025, and December 31, 2024, there
were &lt;span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zgdeHzdfIS8f" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zoYIqa2EltD2" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zsioWnAqeHSa" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zve5lGfOt9cl" title="Preferred Stock, Shares Outstanding"&gt;13,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series B Preferred Stock issued and outstanding. The Series B Preferred Stock does not carry dividend rights
or liquidation preferences separate from common stock unless otherwise provided in its certificate of designation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series C Preferred Stock&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Each share of Series C Preferred Stock
is convertible into 400,000 shares of common stock. Each share carries 400,000 votes per share. Conversion terms are fixed and
not subject to variable price adjustments. The Series C Preferred Stock does not contain a mandatory redemption provision. As of
December 31, 2025, and December 31, 2024, there were &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z1wqmGWqNwq7" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zB0QkcLowcMa" title="Preferred Stock, Shares Outstanding"&gt;9,404&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zMa8ABwVUYI2" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z7O1nlIL4CV9" title="Preferred Stock, Shares Outstanding"&gt;8,249&lt;/span&gt;&lt;/span&gt; shares of Series C Preferred Stock issued and outstanding,
respectively. The Series C Preferred Stock does not carry dividend rights or liquidation preferences separate from common stock
unless otherwise provided in its certificate of designation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series D Preferred Stock&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Each share of Series D Preferred Stock
is convertible into 25,000 shares of common stock and carries 25,000 votes per share. As of December 31, 2025, and December 31,
2024, there were &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zr84aGqMChO3" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_ziC3ViAF3lwk" title="Preferred Stock, Shares Outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zeaOWPBB46u6" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_znvvscOIQxHe" title="Preferred Stock, Shares Outstanding"&gt;700&lt;/span&gt;&lt;/span&gt; shares of Series D Preferred Stock issued and outstanding, respectively. The Series D Preferred Stock
does not carry dividend rights or liquidation preferences separate from common stock unless otherwise provided in its certificate
of designation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series NMC Preferred Stock&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Each share of Series NMC Preferred Stock
is convertible into 500 shares of common stock and carries 500 votes per share. As of December 31, 2025, and December 31, 2024,
there were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zzLemkmUAWQ7" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zhqQ4YXLNksi" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zoR2BLs3NIPk" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zOAGMXu5tqlc" title="Preferred Stock, Shares Outstanding"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series NMC Preferred Stock issued and outstanding. The Series NMC Preferred Stock does not carry
dividend rights or liquidation preferences separate from common stock unless otherwise provided in its certificate of designation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series NMC Preferred Stock includes
a structured sinking fund repurchase mechanism pursuant to which the Company may, at its discretion, make repurchase offers to
holders from time to time. The repurchase price accretes at a rate of &lt;span id="xdx_90F_ecustom--RepurchasePriceAccretesRate_pid_dp_uRatio_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zrwy1nMKbuN4" title="Repurchase price accretes rate"&gt;5&lt;/span&gt;% per annum, subject to a minimum repurchase price of $&lt;span id="xdx_909_ecustom--MinimumRepurchasePrice_iI_pid_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zEOhM5T2fcn6" title="Minimum repurchase price"&gt;25.40&lt;/span&gt;
per share.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Upon the making of a repurchase offer,
each holder must elect either to accept the repurchase price in cash or to convert such holder&#x2019;s shares into common stock
pursuant to the stated conversion ratio. The holder&#x2019;s election is final with respect to that offer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Series NMC Preferred Stock does not
contain a fixed redemption date and does not provide holders with the unilateral right to require cash redemption absent a Company-initiated
offer. Accordingly, the Series NMC Preferred Stock is classified as equity in accordance with ASC 480.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Undesignated Preferred Stock&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is authorized to issue &lt;span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_ztUv9U1Ds8ja" title="Preferred stock, shares authorized"&gt;42,627,000&lt;/span&gt;
shares of undesignated preferred stock. The Board of Directors has the authority, without further shareholder approval, to issue
such shares in one or more series and to determine the voting rights, dividend rights, conversion features, liquidation preferences,
and other terms of each series. &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pid_do_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zhUmfMIOULFb" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zRzTuxp1QMLf" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pid_do_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_ziuhMy0DksQk" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zfIzc4b3CJPc" title="Preferred Stock, Shares Outstanding"&gt;No&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of undesignated preferred stock were issued or outstanding as of December 31, 2025, or
2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Common Stock Activity&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2024,
the Company reclaimed and cancelled &lt;span id="xdx_908_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_pid_uShares_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOmwXY9Vzg2f" title="Common stock reclaimed and cancelled during period, shares"&gt;9,544,690&lt;/span&gt; shares of common stock pursuant to the Final Judgment in &lt;i&gt;SEC v. Keener (1:20-cv-21254-BB)&lt;/i&gt;,
reducing the number of shares outstanding. As of December 31, 2024, the Company had &lt;span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9kAMOqwJhm7" title="Common Stock, Shares, Issued"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMb5C6kcMXs8" title="Common Stock, Shares, Outstanding"&gt;4,347,776,842&lt;/span&gt;&lt;/span&gt; shares of common stock issued
and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025,
the Company issued an aggregate of &lt;span id="xdx_906_ecustom--AggregateShares_iI_pid_uShares_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_za0FnSjIjoK2" title="Aggregate shares"&gt;1,864,000,000&lt;/span&gt; shares of common stock, increasing the total shares outstanding from &lt;span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuoDJW5FflA1" title="Common Stock, Shares, Outstanding"&gt;4,347,776,842&lt;/span&gt;
at December 31, 2024, to &lt;span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zH9vNw0sZMNf" title="Common Stock, Shares, Outstanding"&gt;6,211,776,842&lt;/span&gt; at December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Significant issuances during the year
included:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesIssued1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_za5XP6UfOJDi" title="Conversion of Stock, Shares Issued"&gt;1,500,000,000&lt;/span&gt; shares issued upon conversion of &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zZxBZGM2iVBg" title="Conversion of Stock, Shares Converted"&gt;60,000&lt;/span&gt; shares of Series D Preferred Stock at the
stated conversion rate of &lt;span id="xdx_901_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_z70W7q5tgkG5" title="Number of common shares issued on conversion of one preferred share"&gt;25,000&lt;/span&gt; common shares per preferred share;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zovxubDk4y3k" title="Conversion of Stock, Shares Issued"&gt;342,000,000&lt;/span&gt; shares issued upon conversion of &lt;span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zISNh7hMmZW7" title="Conversion of Stock, Shares Converted"&gt;855&lt;/span&gt; shares of Series C Preferred Stock at the stated
conversion rate of &lt;span id="xdx_90E_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zVBjDgzO5Mpe" title="Number of common shares issued on conversion of one preferred share"&gt;400,000&lt;/span&gt; common shares per preferred share;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_uShares_c20250101__20251231_z9VFfr8qrsU4" title="Shares issued in exchange for equity"&gt;17,000,000&lt;/span&gt; shares issued in exchange for equity securities of Creatd, Inc.; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_902_ecustom--StockIssuedDuringPeriodSharesIssuedForInvestorAwarenessConsultingServices_pid_uShares_c20250101__20251231_zAupsJ5AWKH7" title="Shares issued for consulting services"&gt;5,000,000&lt;/span&gt; shares issued for investor awareness consulting services.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All issuances were recorded at fair value
on the respective issuance dates, with corresponding amounts recognized in additional paid-in capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Preferred Stock Activity&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series A Preferred Stock Activity During
the Period&lt;/b&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zd7GnPq37kV1" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLuXDDj1W392" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zFEeoVzmafP7" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zF3uZc7YGHpc" title="Preferred Stock, Shares Outstanding"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series A Preferred
Stock issued and outstanding as of December 31, 2025, and December 31, 2024, and no issuances, conversions, or other changes occurred
during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series B Preferred Stock Activity During
the Period&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were &lt;span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zItYMTHtGQX7" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zYmV4W5th936" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zvY1EV3zfBga" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zVhbkcPL3sV9" title="Preferred Stock, Shares Outstanding"&gt;13,500&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series B Preferred
Stock issued and outstanding as of December 31, 2025, and December 31, 2024, and no issuances, conversions, or other changes occurred
during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series C Preferred Stock Activity During
the Period&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2024,
the Company issued shares of Series C Preferred Stock for aggregate recorded consideration of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240101__20241231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zfNlPb640oj1" title="Stock sales for the period"&gt;429,480&lt;/span&gt;, consisting of a combination
of cash and non-cash asset contributions, resulting in &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredStocksMember_z78N7tYi5Fg5" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesCPreferredStocksMember_zLqXO4MWRCqe" title="Preferred Stock, Shares Outstanding"&gt;8,249&lt;/span&gt;&lt;/span&gt; shares issued and outstanding, represented by a balance of $&lt;span id="xdx_900_eus-gaap--StockholdersEquity_iI_c20241231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zis6Gf2f0Bc6"&gt;499,485&lt;/span&gt;
at December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025,
the Company issued 2,010 shares of Series C Preferred Stock for aggregate recorded consideration of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zSIhlDTGcfq2" title="Stock sales for the period"&gt;431,700&lt;/span&gt;. During the same period,
&lt;span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zcPTSPdRHFG1" title="Conversion of Series"&gt;855&lt;/span&gt; shares of Series C Preferred Stock were converted into &lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zmq3vIFtHNRc" title="Conversion of series D preferred, shares"&gt;342,000,000&lt;/span&gt; shares of common stock at the stated conversion rate of
&lt;span id="xdx_906_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zgRT0z99zk1d" title="Number of common shares issued on conversion of one preferred share"&gt;400,000&lt;/span&gt; common shares per preferred share, and the carrying value of $&lt;span id="xdx_901_ecustom--StockIssuedDuringPeriodValueSharesIssuedForServicesShares_iN_di_c20250101__20251231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_z912OmCCuEbh" title="Conversion of Series C Preferred into Common (non-cash)"&gt;102,600&lt;/span&gt; associated with those shares was reclassified to
additional paid-in-capital. As a result, Series C Preferred Stock increased from 8,249 shares, represented by a balance of $&lt;span id="xdx_90D_eus-gaap--StockholdersEquity_iI_c20241231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zUdhKKn7RTD8"&gt;499,485&lt;/span&gt;
at December 31, 2024, to 9,404 shares, represented by a balance of $&lt;span id="xdx_906_eus-gaap--StockholdersEquity_iI_c20251231__us-gaap--StatementEquityComponentsAxis__custom--SeriesCPreferredStocksMember_zWk395EDNT5i"&gt;828,585&lt;/span&gt; at December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series D Preferred Stock Activity During
the Period&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2024,
the Company issued &lt;span id="xdx_905_eus-gaap--SharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementEquityComponentsAxis__custom--SeriesDPreferredStocksMember_z0GJUwMRecPl" title="Series D Prefered Stock issued"&gt;700&lt;/span&gt; shares of Series D Preferred Stock for aggregate recorded consideration of $&lt;span id="xdx_906_eus-gaap--StockholdersEquity_iI_c20241231__us-gaap--StatementEquityComponentsAxis__custom--SeriesDPreferredStocksMember_zpFI7uIrPxTi" title="Total consideration"&gt;17,500&lt;/span&gt;, consisting of a combination
of cash and non-cash asset contributions, resulting in 700 shares issued and outstanding at December 31, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025,
the Company issued &lt;span id="xdx_90C_eus-gaap--SharesOutstanding_iI_pid_dxL_uShares_c20251231__us-gaap--StatementEquityComponentsAxis__custom--SeriesDPreferredStocksMember_zAFM9UQF5wI5" title="Series D Prefered Stock issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1048"&gt;59,300&lt;/span&gt;&lt;/span&gt; shares of Series D Preferred Stock for aggregate recorded consideration of $&lt;span id="xdx_907_eus-gaap--StockholdersEquity_iI_dxL_c20251231__us-gaap--StatementEquityComponentsAxis__custom--SeriesDPreferredStocksMember_zxEjEr4wtyC4" title="Total consideration::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1050"&gt;1,482,500&lt;/span&gt;&lt;/span&gt;, consisting of
a combination of cash and non-cash asset contributions, recorded at fair value on the issuance dates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the same period, &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zS7iH0MCP8y5" title="Conversion of Stock, Shares Converted"&gt;60,000&lt;/span&gt; shares of
Series D Preferred Stock, including the 700 shares outstanding at December 31, 2024, were converted into &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesIssued1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zLApGoKAjqc6" title="Conversion of Stock, Shares Issued"&gt;1,500,000,000&lt;/span&gt; shares of
common stock at the stated conversion rate of &lt;span id="xdx_901_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zW3egGF9WuW7" title="Number of common shares issued on conversion of one preferred share"&gt;25,000&lt;/span&gt; common shares per preferred share, and the related carrying value of $1,500,000
was reclassified to additional paid-in capital.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As a result, Series D Preferred Stock decreased
from 700 shares, represented by a balance of $17,500 at December 31, 2024, to zero shares outstanding at December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Series NMC Preferred Stock Activity
During the Period&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;There were &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zOd1V8MI3DG7" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zZhUOHbkGf89" title="Preferred Stock, Shares Outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesIssued_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zbcdKpSMT2vj" title="Preferred Stock, Shares Issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zzwyAVPGszS4" title="Preferred Stock, Shares Outstanding"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; shares of Series NMC
Preferred Stock issued and outstanding as of December 31, 2025, and December 31, 2024, and no issuances, conversions, or redemptions
occurred during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Warrants and Contractual Purchase Rights&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_90C_ecustom--WarrantsAndContractualPurchaseRights_c20250101__20251231_zPPq1SamrJWb" title="Warrants and contractual purchase rights"&gt;As of December 31, 2024, the Company had
outstanding contractual purchase rights and warrants exercisable into 5,847,900,000 shares of common stock, consisting of 3,201
Series C contractual purchase rights, 2,750 Series C warrants, 700 Series D warrants, and 6,900,000 Series NMC warrants. Changes
during the year ended December 31, 2025, primarily reflect the exercise of certain Series C contractual purchase rights and the
issuance of additional Series D warrants in connection with financing transactions.&lt;/span&gt; The net increase in shares issuable during
2025 was primarily attributable to the issuance of Series D warrants issued in connection with financing transactions involving
Series D Convertible Preferred Stock, partially offset by the exercise of certain Series C contractual purchase rights.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the Company had
outstanding contractual purchase rights and warrants exercisable pursuant to fixed contractual terms as defined in the respective
agreements. These instruments are classified as equity in accordance with ASC 815-40 and ASC 480, as they are indexed to the Company&#x2019;s
own stock and do not require net cash settlement or otherwise meet the criteria for liability classification.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes these instruments
as of December 31, 2025:&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfInstrumentsTableTextBlock_zLqpmqcWM52a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: justify"&gt;&#160;&lt;span id="xdx_8B1_zu7eVXvS2UFi" style="display: none"&gt;Schedule of instruments&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 95%"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 35%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Instrument&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Instruments &lt;br/&gt;
Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common Shares &lt;br/&gt;
Issuable per Instrument&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total Common Shares&lt;br/&gt;
 Issuable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series C contractual purchase rights (bespoke options)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCContractualPurchaseRightsMember_zYlZJjeMvVr3" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;1,861&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCContractualPurchaseRightsMember_znhBIKMFXe35" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCContractualPurchaseRightsMember_znLj3mYFxoR1" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;744,400,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series C warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_ze9G1CFIKTWg" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;2,750&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zEuAUjTVCHOd" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zlUT0TTDruPc" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;1,100,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series D warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zMSjZwd4QbUk" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;60,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zc0hSX0UNjEj" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_z6enFWCF2xs2" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;1,500,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series NMC warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCWarrantsMember_zErfDPvF3Jgj" style="border-bottom: Black 1pt solid; padding-top: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;6,900,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCWarrantsMember_zGcIpB4Nk8pl" style="border-bottom: Black 1pt solid; padding-top: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCWarrantsMember_zV3cdgx4Qnj2" style="border-bottom: Black 1pt solid; padding-top: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;3,450,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InstrumentsSharesOutstanding_iI_pid_d0_uShares_c20251231_zBecgJ4F9Nhd" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#x2014;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CommonSharesIssuablePerInstrument_iI_pid_d0_uShares_c20251231_zr5GG0EekCP7" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#x2014;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231_z7jWZoPxaWJ7" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;6,794,400,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zOxIwrXVROb5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If exercised in full, these contractual
purchase rights and warrants would result in the issuance of up to &lt;span id="xdx_909_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231_zG9bOOWJQSxg" title="Total common shares issuable"&gt;6,794,400,000&lt;/span&gt; additional shares of the Company&#x2019;s common
stock, resulting in substantial dilution to existing common shareholders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Convertible Preferred Stock&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2024, the Company had
outstanding convertible preferred stock that was convertible into &lt;span id="xdx_90C_ecustom--ConvertiblePreferredStock_iI_pid_uShares_c20241231_zm0pYd6CgcG9" title="Convertible preferred stock"&gt;6,780,600,000&lt;/span&gt; shares of common stock pursuant to fixed conversion
ratios.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the Company had
outstanding shares of convertible preferred stock that were convertible into shares of the Company&#x2019;s common stock pursuant
to fixed conversion ratios defined in the respective certificates of designation. These preferred shares are classified as equity
in accordance with ASC 480 and ASC 815-40.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table summarizes the preferred
stock outstanding and the number of common shares issuable upon conversion as of December 31, 2025:&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfPreferredStockOutstandingTableTextBlock_zg365kWhevxl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8B1_z0LHNdjgFXe8" style="display: none"&gt;Schedule of preferred stock outstanding&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Preferred &lt;br/&gt;
Shares &lt;br/&gt;
Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Conversion &lt;br/&gt;
Ratio (Common &lt;br/&gt;
per Preferred)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common Shares &lt;br/&gt;
Issuable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zgZpMtrv85M6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;13,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXslyD6J6c9a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQmj7E4sqzl6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;13,500,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Series C Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zjc7B7ZB2Vv2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;9,404&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zKLARcftaW36" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zgyGz0A1lxl7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;3,761,600,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Series NMC Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCConvertiblePreferredStockMember_z71yS8dZ3vf8" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;6,900,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCConvertiblePreferredStockMember_zjALMJdUkIJl" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCConvertiblePreferredStockMember_zfkQqOS4Iqdb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;3,450,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231_ziiqWcKUw5ai" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1126"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231_zOm0ag6uXk09" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231_zLr9PON0eadi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;7,225,100,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A8_zUdiFcdHueQ5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;If fully converted, these preferred shares would result in the
issuance of up to &lt;span id="xdx_909_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231_zaYq9NPLRL0f" title="Common shares issuable"&gt;7,225,100,000&lt;/span&gt; additional shares of common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Equity Classification of Convertible Instruments, Contractual
Purchase Rights, and Warrants&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;All outstanding convertible preferred stock,
contractual purchase rights, and warrants are classified as equity instruments in accordance with ASC 480, &lt;i&gt;Distinguishing Liabilities
from Equity&lt;/i&gt;, and ASC 815-40, &lt;i&gt;Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity&lt;/i&gt;. These instruments
are indexed to the Company&#x2019;s own common stock and provide for settlement through the issuance of a fixed or determinable
number of shares. None of these instruments require or permit net cash settlement, and the Company does not have an obligation
to repurchase or redeem the instruments for cash or other assets. Accordingly, these instruments meet the criteria for equity classification
and are presented as components of shareholders&#x2019; equity in the accompanying consolidated balance sheets.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Shares Reserved for Future Issuance&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, approximately
14,019,500,000 shares of the Company&#x2019;s common stock were potentially issuable upon conversion of outstanding convertible
preferred stock and the exercise of outstanding contractual purchase rights and warrants. The Company had 13,788,223,158 authorized
but unissued shares of common stock available as of that date. Accordingly, the number of shares issuable upon conversion and exercise
exceeded the number of authorized but unissued shares available as of December 31, 2025. The Company does not have a present obligation
to issue shares in excess of its authorized share capital, and issuance of any additional shares beyond the authorized amount would
require shareholder approval to amend the Company&#x2019;s Certificate of Formation. No liability has been recorded in connection
with these instruments, as settlement in shares in excess of authorized amounts is not presently required and remains subject to
corporate authorization.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Earnings Per Share&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Basic earnings (loss) per share is computed
by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding
during the period.&#160;Net income attributable to common stockholders reflects the deduction of cumulative dividends on the Company&#x2019;s
Series A Preferred Stock totaling $&lt;span id="xdx_905_eus-gaap--PreferredStockDividendsAndOtherAdjustments_c20240101__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z5RhAct2GTl7"&gt;10,500&lt;/span&gt; for the year ended December 31, 2024. For the year ended December 31, 2025, the Company
reported a net loss and therefore the Series A preferred dividend was not deducted in computing loss per share.&#160;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Diluted earnings (loss) per share reflects
the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into
common stock. The Company applies the if-converted method for convertible preferred stock and the treasury stock method for warrants
and contractual rights, in accordance with ASC 260.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table sets forth the computation
of earnings (loss) per share:&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdPsj7y0w2o5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8BB_zGqlo6HKMK74" style="display: none"&gt;Schedule of earnings per share&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0.75pt; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year
    Ended December 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year
    Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    income (loss)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProfitLoss_c20250101__20251231_zMeeSFAnUI27" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(291,519)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProfitLoss_c20240101__20241231_zKvLbaInsSk6" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$396,762&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
                                            Series A preferred dividend&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;


&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--PreferredStockDividendsAndOtherAdjustments_d0_c20250101__20251231_zZejbeSYoHde" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;

&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--PreferredStockDividendsAndOtherAdjustments_c20240101__20241231_zfqTbIOQzm04" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(10,500)&lt;/span&gt;

&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                            income (loss) attributable to common stockholders&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;


&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20250101__20251231_zKWWQonoauIa" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(291,519)&lt;/span&gt;

&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240101__20241231_zbi8tMSURdXf" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$386,262&lt;/span&gt;

&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares &#x2013; basic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20250101__20251231_zSO9s5DUIUfg" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  basic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,835,385,747&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240101__20241231_z1uJlJchb67a" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  basic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,352,178,005&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    earnings (loss) per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20250101__20251231_zKuBwxKz31Uh" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Basic earnings (loss) per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(0.00006)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240101__20241231_zoNyJALAtipj" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Basic earnings (loss) per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.000089&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares &#x2013; diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20250101__20251231_zgXCmsH0uv91" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,835,385,747&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240101__20241231_zhxnHaaVsVr2" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,953,338,005&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
    earnings (loss) per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20250101__20251231_zfcRPpANjjsb" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Diluted earnings (loss) per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(0.00006)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pid_dxL_uUSDPShares_c20240101__20241231_zR4rI9AFFTdb" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Diluted earnings (loss) per share::XDX::0.000065"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1164"&gt;$0.000065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8AA_ztE27a7yKMwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2024,
diluted earnings per share reflects the inclusion of incremental shares resulting from in-the-money Series C contractual purchase
rights and Series C warrants, calculated using the treasury stock method in accordance with ASC 260-10-45-11. The weighted average
shares outstanding were increased by 501,160,000 shares related to contractual purchase rights and &lt;span id="xdx_906_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20241231_zvmCnCvfWjb8" title="Total common shares issuable"&gt;1,100,000,000&lt;/span&gt; shares related
to warrants, resulting in total diluted weighted average shares outstanding of &lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240101__20241231_zFsEBs31U2P6" title="Weighted average shares  diluted"&gt;5,953,338,005&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the year ended December 31, 2025, the
Company reported a net loss. Accordingly, all potentially dilutive securities were excluded from the calculation of diluted net
loss per share because their inclusion would have been anti-dilutive.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Potentially dilutive securities excluded
for 2025 included:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Series A Preferred Stock&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Series B Preferred Stock&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Series C Convertible Preferred Stock&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Series D Convertible Preferred Stock&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Series NMC $25 Convertible Preferred Stock&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Outstanding warrants and contractual purchase rights&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;For the year ended December 31, 2024, diluted earnings per share
reflects the inclusion of dilutive contractual purchase rights and warrants calculated using the treasury stock method. Convertible
preferred stock was excluded because its inclusion would have been anti-dilutive.&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000870">&lt;p id="xdx_89B_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_z3xQ15mB8uqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, and December 31,
2024, the following classes and series of capital stock were authorized and issued and outstanding. The table below also summarizes
the par value, voting rights, and conversion terms applicable to each class and series.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BB_zS7SfjeGFvZf" style="display: none; visibility: hidden"&gt;Schedule of stockholders equity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Par &lt;br/&gt;
Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Authorized&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;br/&gt;
 12/31/2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Outstanding &lt;br/&gt;
12/31/2024&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Votes Per &lt;br/&gt;
Share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Conversion &lt;br/&gt;
Ratio&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Common&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231_zcUmwlUqF7Qb" title="Par Value"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_uShares_c20251231_zO7uevHnCx28" title="Authorized Shares"&gt;20,000,000,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20251231_zufv6cN1x4dc" title="Outstanding Shares"&gt;6,211,776,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_uShares_c20241231_z0nG4vCpLDwh" title="Outstanding Shares"&gt;4,347,776,842&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--CommonStockVotingRights_c20250101__20251231_zufSsirmqzz3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Voting Rights"&gt;&lt;span style="font-size: 10pt"&gt;1 vote per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbgbg19aRyad"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zJXxhJ2ccxO3"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zLipodDEH3xc"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zT7XDYd5w7y"&gt;105,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdZIjnkF9zyb"&gt;3,000 votes per share&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series B&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zIg6B9OpPSSl"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zdh5tOREKx9g"&gt;33,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zbVgsB45Mcqe"&gt;13,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfxtqRGpYVx"&gt;13,500&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFyuCxUmN9Kd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1,000 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zw8S1xblBd9j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center" title="Conversion terms"&gt;&lt;span style="font-size: 10pt"&gt;1 : 1,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series C&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zDhZ1xH0pa8e"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zJPy5R6GeBzb"&gt;100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zFHieWEZSrCk"&gt;9,404&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zGrtPHQJHit6"&gt;8,249&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zvpHDn2aHJF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;400,000 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zMHTFmxfMBBj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1 : 400,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series D&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zQlQczK3VCdj"&gt;25&lt;/span&gt; par &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zacqo98rW1J2"&gt;35,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_ztMVTPjlQytk"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_z9jrfOBwSkD9"&gt;700&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zHTzZAPJIRHb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;25,000 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zB401VmhTjY9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1 : 25,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Series NMC&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zbvIXV7N97Ej"&gt;25&lt;/span&gt; par &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zfUT1utelL2k"&gt;7,100,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_za5szClHNTj"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zEqPj1HZrD22"&gt;6,900,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--PreferredStockVotingRights_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_z6goMfYxFm95" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&#160;500 votes per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--ConvertiblePreferredStockTermsOfConversion_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCPreferredStockMember_zssxBgxNFlJd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1 : 500&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Undesignated Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_do_uUSDPShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_z6Ot40d5Ctj6"&gt;No&lt;/span&gt; par&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zLmszU33ZCI4"&gt;42,627,000&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_zrxb2vUJZod1"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20241231__us-gaap--StatementClassOfStockAxis__custom--UndesignatedPreferredstockMember_ziVK626DToEg"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000872"
      unitRef="USDPShares">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000874"
      unitRef="Shares">20000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000876"
      unitRef="Shares">6211776842</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000878"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockVotingRights contextRef="From2025-01-01to2025-12-31" id="Fact000880">1 vote per share</us-gaap:CommonStockVotingRights>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000881"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000882"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000883"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000884"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesAPreferredStockMember"
      id="Fact000885">3,000 votes per share</us-gaap:PreferredStockVotingRights>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000886"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000887"
      unitRef="Shares">33000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000888"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000889"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember"
      id="Fact000890">1,000 votes per share</us-gaap:PreferredStockVotingRights>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember"
      id="Fact000892">1 : 1,000</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000893"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000894"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000895"
      unitRef="Shares">9404</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000896"
      unitRef="Shares">8249</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      id="Fact000897">400,000 votes per share</us-gaap:PreferredStockVotingRights>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      id="Fact000898">1 : 400,000</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000899"
      unitRef="USDPShares">25</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000900"
      unitRef="Shares">35000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000901"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000902"
      unitRef="Shares">700</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      id="Fact000903">25,000 votes per share</us-gaap:PreferredStockVotingRights>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      id="Fact000904">1 : 25,000</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000905"
      unitRef="USDPShares">25</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000906"
      unitRef="Shares">7100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000907"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000908"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember"
      id="Fact000909">&#160;500 votes per share</us-gaap:PreferredStockVotingRights>
    <us-gaap:ConvertiblePreferredStockTermsOfConversion
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember"
      id="Fact000910">1 : 500</us-gaap:ConvertiblePreferredStockTermsOfConversion>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000911"
      unitRef="USDPShares">0</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000912"
      unitRef="Shares">42627000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000913"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000914"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000917"
      unitRef="Shares">6211776842</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000919"
      unitRef="Shares">6211776842</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000921"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact000923"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000925"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000927"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000929"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000931"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000933"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000935"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000937"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact000939"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000941"
      unitRef="Shares">9404</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000943"
      unitRef="Shares">9404</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000945"
      unitRef="Shares">8249</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000947"
      unitRef="Shares">8249</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000949"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000951"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000953"
      unitRef="Shares">700</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000955"
      unitRef="Shares">700</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000958"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000960"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000962"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000964"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <rite:RepurchasePriceAccretesRate
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000966"
      unitRef="Ratio">0.05</rite:RepurchasePriceAccretesRate>
    <rite:MinimumRepurchasePrice
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact000968"
      unitRef="USDPShares">25.40</rite:MinimumRepurchasePrice>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000970"
      unitRef="Shares">42627000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000972"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000974"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000976"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_UndesignatedPreferredstockMember"
      decimals="INF"
      id="Fact000978"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="From2024-01-012024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000980"
      unitRef="Shares">9544690</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000982"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000984"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesOutstanding>
    <rite:AggregateShares
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000986"
      unitRef="Shares">1864000000</rite:AggregateShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000988"
      unitRef="Shares">4347776842</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000990"
      unitRef="Shares">6211776842</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000992"
      unitRef="Shares">1500000000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000994"
      unitRef="Shares">60000</us-gaap:ConversionOfStockSharesConverted1>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact000996"
      unitRef="Shares">25000</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact000998"
      unitRef="Shares">342000000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001000"
      unitRef="Shares">855</us-gaap:ConversionOfStockSharesConverted1>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001002"
      unitRef="Shares">400000</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001004"
      unitRef="Shares">17000000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <rite:StockIssuedDuringPeriodSharesIssuedForInvestorAwarenessConsultingServices
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001006"
      unitRef="Shares">5000000</rite:StockIssuedDuringPeriodSharesIssuedForInvestorAwarenessConsultingServices>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001009"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001011"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001013"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001015"
      unitRef="Shares">105000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001017"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001019"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001021"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001023"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-01-012024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact001025"
      unitRef="USD">429480</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember212187796"
      decimals="INF"
      id="Fact001027"
      unitRef="Shares">8249</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember212187796"
      decimals="INF"
      id="Fact001029"
      unitRef="Shares">8249</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact001030"
      unitRef="USD">499485</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact001032"
      unitRef="USD">431700</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="INF"
      id="Fact001034"
      unitRef="Shares">855</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001036"
      unitRef="Shares">342000000</us-gaap:ConversionOfStockSharesIssued1>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001038"
      unitRef="Shares">400000</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <rite:StockIssuedDuringPeriodValueSharesIssuedForServicesShares
      contextRef="From2025-01-012025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact001040"
      unitRef="USD">-102600</rite:StockIssuedDuringPeriodValueSharesIssuedForServicesShares>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact001041"
      unitRef="USD">499485</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-12-31_custom_SeriesCPreferredStocksMember"
      decimals="0"
      id="Fact001042"
      unitRef="USD">828585</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="INF"
      id="Fact001044"
      unitRef="Shares">700</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_SeriesDPreferredStocksMember"
      decimals="0"
      id="Fact001046"
      unitRef="USD">17500</us-gaap:StockholdersEquity>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact001052"
      unitRef="Shares">60000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact001054"
      unitRef="Shares">1500000000</us-gaap:ConversionOfStockSharesIssued1>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="INF"
      id="Fact001056"
      unitRef="Shares">25000</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact001059"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact001061"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact001063"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-12-31_custom_SeriesNMCPreferredStockMember"
      decimals="INF"
      id="Fact001065"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <rite:WarrantsAndContractualPurchaseRights contextRef="From2025-01-01to2025-12-31" id="Fact001067">As of December 31, 2024, the Company had
outstanding contractual purchase rights and warrants exercisable into 5,847,900,000 shares of common stock, consisting of 3,201
Series C contractual purchase rights, 2,750 Series C warrants, 700 Series D warrants, and 6,900,000 Series NMC warrants. Changes
during the year ended December 31, 2025, primarily reflect the exercise of certain Series C contractual purchase rights and the
issuance of additional Series D warrants in connection with financing transactions.</rite:WarrantsAndContractualPurchaseRights>
    <rite:ScheduleOfInstrumentsTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001069">&lt;p id="xdx_89D_ecustom--ScheduleOfInstrumentsTableTextBlock_zLqpmqcWM52a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; display: none; text-align: justify"&gt;&#160;&lt;span id="xdx_8B1_zu7eVXvS2UFi" style="display: none"&gt;Schedule of instruments&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 95%"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 35%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Instrument&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Instruments &lt;br/&gt;
Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common Shares &lt;br/&gt;
Issuable per Instrument&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 20%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total Common Shares&lt;br/&gt;
 Issuable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series C contractual purchase rights (bespoke options)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCContractualPurchaseRightsMember_zYlZJjeMvVr3" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;1,861&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCContractualPurchaseRightsMember_znhBIKMFXe35" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCContractualPurchaseRightsMember_znLj3mYFxoR1" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;744,400,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series C warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_ze9G1CFIKTWg" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;2,750&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zEuAUjTVCHOd" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCWarrantsMember_zlUT0TTDruPc" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;1,100,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series D warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zMSjZwd4QbUk" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;60,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_zc0hSX0UNjEj" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;25,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesDWarrantsMember_z6enFWCF2xs2" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;1,500,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-top: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;Series NMC warrants&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InstrumentsSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCWarrantsMember_zErfDPvF3Jgj" style="border-bottom: Black 1pt solid; padding-top: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;6,900,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CommonSharesIssuablePerInstrument_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCWarrantsMember_zGcIpB4Nk8pl" style="border-bottom: Black 1pt solid; padding-top: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCWarrantsMember_zV3cdgx4Qnj2" style="border-bottom: Black 1pt solid; padding-top: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;3,450,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InstrumentsSharesOutstanding_iI_pid_d0_uShares_c20251231_zBecgJ4F9Nhd" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Instruments outstanding"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#x2014;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CommonSharesIssuablePerInstrument_iI_pid_d0_uShares_c20251231_zr5GG0EekCP7" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Common shares issuable per instrument"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&#x2014;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TotalCommonSharesIssuable_iI_pid_uShares_c20251231_z7jWZoPxaWJ7" style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Total common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;6,794,400,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</rite:ScheduleOfInstrumentsTableTextBlock>
    <rite:InstrumentsSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCContractualPurchaseRightsMember"
      decimals="INF"
      id="Fact001071"
      unitRef="Shares">1861</rite:InstrumentsSharesOutstanding>
    <rite:CommonSharesIssuablePerInstrument
      contextRef="AsOf2025-12-31_custom_SeriesCContractualPurchaseRightsMember"
      decimals="INF"
      id="Fact001073"
      unitRef="Shares">400000</rite:CommonSharesIssuablePerInstrument>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesCContractualPurchaseRightsMember"
      decimals="INF"
      id="Fact001075"
      unitRef="Shares">744400000</rite:TotalCommonSharesIssuable>
    <rite:InstrumentsSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesCWarrantsMember"
      decimals="INF"
      id="Fact001077"
      unitRef="Shares">2750</rite:InstrumentsSharesOutstanding>
    <rite:CommonSharesIssuablePerInstrument
      contextRef="AsOf2025-12-31_custom_SeriesCWarrantsMember"
      decimals="INF"
      id="Fact001079"
      unitRef="Shares">400000</rite:CommonSharesIssuablePerInstrument>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesCWarrantsMember"
      decimals="INF"
      id="Fact001081"
      unitRef="Shares">1100000000</rite:TotalCommonSharesIssuable>
    <rite:InstrumentsSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact001083"
      unitRef="Shares">60000</rite:InstrumentsSharesOutstanding>
    <rite:CommonSharesIssuablePerInstrument
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact001085"
      unitRef="Shares">25000</rite:CommonSharesIssuablePerInstrument>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesDWarrantsMember"
      decimals="INF"
      id="Fact001087"
      unitRef="Shares">1500000000</rite:TotalCommonSharesIssuable>
    <rite:InstrumentsSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesNMCWarrantsMember"
      decimals="INF"
      id="Fact001089"
      unitRef="Shares">6900000</rite:InstrumentsSharesOutstanding>
    <rite:CommonSharesIssuablePerInstrument
      contextRef="AsOf2025-12-31_custom_SeriesNMCWarrantsMember"
      decimals="INF"
      id="Fact001091"
      unitRef="Shares">500</rite:CommonSharesIssuablePerInstrument>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2025-12-31_custom_SeriesNMCWarrantsMember"
      decimals="INF"
      id="Fact001093"
      unitRef="Shares">3450000000</rite:TotalCommonSharesIssuable>
    <rite:InstrumentsSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact001095"
      unitRef="Shares">0</rite:InstrumentsSharesOutstanding>
    <rite:CommonSharesIssuablePerInstrument
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact001097"
      unitRef="Shares">0</rite:CommonSharesIssuablePerInstrument>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact001099"
      unitRef="Shares">6794400000</rite:TotalCommonSharesIssuable>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact001101"
      unitRef="Shares">6794400000</rite:TotalCommonSharesIssuable>
    <rite:ConvertiblePreferredStock
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001103"
      unitRef="Shares">6780600000</rite:ConvertiblePreferredStock>
    <rite:ScheduleOfPreferredStockOutstandingTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001106">&lt;p id="xdx_89A_ecustom--ScheduleOfPreferredStockOutstandingTableTextBlock_zg365kWhevxl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8B1_z0LHNdjgFXe8" style="display: none"&gt;Schedule of preferred stock outstanding&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"&gt;
&lt;tr&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 54%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Series&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Preferred &lt;br/&gt;
Shares &lt;br/&gt;
Outstanding&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Conversion &lt;br/&gt;
Ratio (Common &lt;br/&gt;
per Preferred)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Common Shares &lt;br/&gt;
Issuable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Series B Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zgZpMtrv85M6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;13,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zXslyD6J6c9a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;1,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zQmj7E4sqzl6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;13,500,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Series C Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zjc7B7ZB2Vv2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;9,404&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zKLARcftaW36" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;400,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zgyGz0A1lxl7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;3,761,600,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;Series NMC Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCConvertiblePreferredStockMember_z71yS8dZ3vf8" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;6,900,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCConvertiblePreferredStockMember_zjALMJdUkIJl" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesNMCConvertiblePreferredStockMember_zfkQqOS4Iqdb" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;3,450,000,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--PreferredStockSharesOutstanding_iI_pid_uShares_c20251231_ziiqWcKUw5ai" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preferred stock outstanding"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1126"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare_pid_uShares_c20250101__20251231_zOm0ag6uXk09" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Conversion of stock, shares converted"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1128"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ConversionOfStockCommonSharesIssued_pid_uShares_c20250101__20251231_zLr9PON0eadi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Common shares issuable"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;7,225,100,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</rite:ScheduleOfPreferredStockOutstandingTableTextBlock>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001108"
      unitRef="Shares">13500</us-gaap:PreferredStockSharesOutstanding>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001110"
      unitRef="Shares">1000</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <rite:ConversionOfStockCommonSharesIssued
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001112"
      unitRef="Shares">13500000</rite:ConversionOfStockCommonSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001114"
      unitRef="Shares">9404</us-gaap:PreferredStockSharesOutstanding>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001116"
      unitRef="Shares">400000</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <rite:ConversionOfStockCommonSharesIssued
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001118"
      unitRef="Shares">3761600000</rite:ConversionOfStockCommonSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-12-31_custom_SeriesNMCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001120"
      unitRef="Shares">6900000</us-gaap:PreferredStockSharesOutstanding>
    <rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001122"
      unitRef="Shares">500</rite:NumberOfCommonSharesIssuedOnConversionOfOnePreferredShare>
    <rite:ConversionOfStockCommonSharesIssued
      contextRef="From2025-01-012025-12-31_custom_SeriesNMCConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001124"
      unitRef="Shares">3450000000</rite:ConversionOfStockCommonSharesIssued>
    <rite:ConversionOfStockCommonSharesIssued
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001130"
      unitRef="Shares">7225100000</rite:ConversionOfStockCommonSharesIssued>
    <rite:ConversionOfStockCommonSharesIssued
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001132"
      unitRef="Shares">7225100000</rite:ConversionOfStockCommonSharesIssued>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="From2024-01-012024-12-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact001134"
      unitRef="USD">10500</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001136">&lt;p id="xdx_895_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zdPsj7y0w2o5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span id="xdx_8BB_zGqlo6HKMK74" style="display: none"&gt;Schedule of earnings per share&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 90%; margin-right: auto"&gt;
&lt;tr&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding: 0.75pt; width: 40%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year
    Ended December 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right; width: 20%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Year
    Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    income (loss)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--ProfitLoss_c20250101__20251231_zMeeSFAnUI27" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(291,519)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--ProfitLoss_c20240101__20241231_zKvLbaInsSk6" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$396,762&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Less:
                                            Series A preferred dividend&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;


&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--PreferredStockDividendsAndOtherAdjustments_d0_c20250101__20251231_zZejbeSYoHde" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;

&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--PreferredStockDividendsAndOtherAdjustments_c20240101__20241231_zfqTbIOQzm04" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(10,500)&lt;/span&gt;

&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
                                            income (loss) attributable to common stockholders&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;


&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20250101__20251231_zKWWQonoauIa" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(291,519)&lt;/span&gt;

&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_c20240101__20241231_zbi8tMSURdXf" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Net income (loss)"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$386,262&lt;/span&gt;

&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares &#x2013; basic&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20250101__20251231_zSO9s5DUIUfg" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  basic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,835,385,747&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_uShares_c20240101__20241231_z1uJlJchb67a" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  basic"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,352,178,005&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
    earnings (loss) per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20250101__20251231_zKuBwxKz31Uh" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Basic earnings (loss) per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(0.00006)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--EarningsPerShareBasic_pid_uUSDPShares_c20240101__20241231_zoNyJALAtipj" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Basic earnings (loss) per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$0.000089&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Weighted
    average shares &#x2013; diluted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20250101__20251231_zgXCmsH0uv91" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,835,385,747&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_uShares_c20240101__20241231_zhxnHaaVsVr2" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Weighted average shares  diluted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,953,338,005&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Diluted
    earnings (loss) per share&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--EarningsPerShareDiluted_pid_uUSDPShares_c20250101__20251231_zfcRPpANjjsb" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Diluted earnings (loss) per share"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$(0.00006)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--EarningsPerShareDiluted_pid_dxL_uUSDPShares_c20240101__20241231_zR4rI9AFFTdb" style="font: 10pt Times New Roman, Times, Serif; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: right" title="Diluted earnings (loss) per share::XDX::0.000065"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1164"&gt;$0.000065&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ProfitLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact001138"
      unitRef="USD">-291519</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001140"
      unitRef="USD">396762</us-gaap:ProfitLoss>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact001142"
      unitRef="USD">0</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:PreferredStockDividendsAndOtherAdjustments
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001144"
      unitRef="USD">-10500</us-gaap:PreferredStockDividendsAndOtherAdjustments>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact001146"
      unitRef="USD">-291519</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact001148"
      unitRef="USD">386262</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001150"
      unitRef="Shares">4835385747</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001152"
      unitRef="Shares">4352178005</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001154"
      unitRef="USDPShares">-0.00006</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001156"
      unitRef="USDPShares">0.000089</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001158"
      unitRef="Shares">4835385747</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001160"
      unitRef="Shares">5953338005</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-01-01to2025-12-31"
      decimals="INF"
      id="Fact001162"
      unitRef="USDPShares">-0.00006</us-gaap:EarningsPerShareDiluted>
    <rite:TotalCommonSharesIssuable
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001166"
      unitRef="Shares">1100000000</rite:TotalCommonSharesIssuable>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-01-012024-12-31"
      decimals="INF"
      id="Fact001168"
      unitRef="Shares">5953338005</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001170">&lt;p id="xdx_80E_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zDcvRfkzh04h" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(15) &lt;span id="xdx_822_z7DcRUs2yAUg"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Accounting Policy&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for share-based compensation
in accordance with ASC 718, &lt;i&gt;Compensation&#x2014;Stock Compensation&lt;/i&gt;. Equity instruments issued in exchange for goods or services
are measured at their grant-date fair value and recognized as compensation expense over the requisite service period. When equity
instruments are fully vested at grant but relate to future service obligations, the Company records the grant-date fair value as
a prepaid asset and amortizes such amount ratably over the service period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Investment Banking Services&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025,
the Company issued Series C Convertible Preferred Stock in exchange for investment banking services under two separate agreements
with different investment banking firms.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In February 2025, the Company issued &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_uShares_c20250201__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zCz8tcMN04Gd"&gt;90&lt;/span&gt;
shares of Series C Convertible Preferred Stock. The shares were fully vested at grant. The aggregate grant-date fair value of these
shares was $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zFkt8E5tXPN3"&gt;39,600&lt;/span&gt;, which was recognized as expense during the year ended December 31, 2025. Pursuant to the agreement, if no financing
transaction occurs during the engagement term, the service provider has agreed to return &lt;span id="xdx_905_ecustom--ContingentShareReturnPercentageIfNoFinancingTransaction_pid_dp_uRatio_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zpS38JcAxVtb" title="Contingent Share Return Percentage If No Financing Transaction"&gt;50&lt;/span&gt;% of the shares issued. As of December
31, 2025, all shares remain issued and outstanding.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In a separate ten-month investment banking
engagement beginning in 2025 with a different investment banking firm, the Company granted a minimum of 50 shares of Series C Convertible
Preferred Stock. The aggregate grant-date fair value of these shares was determined to be $&lt;span id="xdx_900_ecustom--AggregateGrantFairValue_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zoNW8SaL5DXh" title="Aggregate grant-date fair value"&gt;134,000&lt;/span&gt;. Although the shares were fully
vested at grant, they relate to a ten-month service obligation. Accordingly, the Company recorded the grant-date fair value as
prepaid consulting expense and recognizes compensation expense ratably over the service period. During the year ended December
31, 2025, the Company recognized $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensation_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z7hZpsAKf5hc"&gt;26,800&lt;/span&gt; of expense related to this engagement. As of December 31, 2025, $&lt;span id="xdx_90E_ecustom--PrepaidExpensesCurrent_iI_uUSD_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z9uHnPVHom1l" title="Prepaid expenses, current"&gt;107,200&lt;/span&gt; remained unrecognized
and is included in prepaid expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Investor Outreach Services&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In October 2025, the Company issued &lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_uShares_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zn1cqrF2VkZa" title="Common stock, issued"&gt;5,000,000&lt;/span&gt;
shares of common stock in exchange for investor awareness consulting services under a six-month agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The aggregate grant-date fair value of
the shares was determined to be $&lt;span id="xdx_903_ecustom--AggregateGrantFairValue_iI_c20251031__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoSUxBnXFK5a" title="Aggregate grant-date fair value"&gt;31,000&lt;/span&gt;. Because the shares relate to a six-month service period, the Company recorded the fair
value as prepaid consulting expense and recognizes compensation expense ratably over the service term. During the year ended December
31, 2025, the Company recognized $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensation_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zqslh8Phc7pk" title="Share-Based Compensation"&gt;10,333&lt;/span&gt; of stock-based compensation expense related to this agreement. As of December 31, 2025,
$&lt;span id="xdx_905_eus-gaap--PrepaidExpenseCurrent_iI_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsmNFHkpAmuk"&gt;20,667&lt;/span&gt; remained unrecognized and is included in prepaid expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Total Stock-Based Compensation Expense&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the year ended December 31, 2025, the
Company recognized total stock-based compensation expense of $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensation_c20250101__20251231_zCYnJJdSywA3"&gt;81,733&lt;/span&gt;. Included in this amount is $&lt;span id="xdx_90B_ecustom--PricingDiscount_iI_c20251231_zIUQyeohvoAe" title="Pricing discount"&gt;5,000&lt;/span&gt; related to a pricing discount
provided in connection with a Series C preferred stock issuance.&lt;/p&gt;

</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-02-012025-02-28_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001171"
      unitRef="Shares">90</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact001172"
      unitRef="USD">39600</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <rite:ContingentShareReturnPercentageIfNoFinancingTransaction
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001174"
      unitRef="Ratio">0.50</rite:ContingentShareReturnPercentageIfNoFinancingTransaction>
    <rite:AggregateGrantFairValue
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact001176"
      unitRef="USD">134000</rite:AggregateGrantFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact001177"
      unitRef="USD">26800</us-gaap:ShareBasedCompensation>
    <rite:PrepaidExpensesCurrent
      contextRef="AsOf2025-12-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact001179"
      unitRef="USD">107200</rite:PrepaidExpensesCurrent>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-10-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001181"
      unitRef="Shares">5000000</us-gaap:CommonStockSharesIssued>
    <rite:AggregateGrantFairValue
      contextRef="AsOf2025-10-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001183"
      unitRef="USD">31000</rite:AggregateGrantFairValue>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001185"
      unitRef="USD">10333</us-gaap:ShareBasedCompensation>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-12-31_us-gaap_CommonStockMember212189015"
      decimals="0"
      id="Fact001186"
      unitRef="USD">20667</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact001188"
      unitRef="USD">81733</us-gaap:ShareBasedCompensation>
    <rite:PricingDiscount
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001190"
      unitRef="USD">5000</rite:PricingDiscount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001192">&lt;p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zkN3DAJcGYB" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(16) &lt;span id="xdx_82A_z1vk1m4ERZh1"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates commitments and contingencies
in accordance with ASC 450, &lt;i&gt;Contingencies&lt;/i&gt;. A liability is recognized when it is probable that a loss has been incurred and
the amount of loss can be reasonably estimated. If a loss is reasonably possible but not probable, the Company discloses the nature
of the contingency and an estimate of possible loss, or a statement that such estimate cannot be made.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company may be subject to contractual
commitments, regulatory matters, environmental obligations, indemnification arrangements, guarantee arrangements, and legal proceedings
in the ordinary course of business. As of December 31, 2025, the Company is not aware of any such matters that would have a material
adverse effect on its financial position, results of operations, or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;From time to time, the Company may receive
informal assertions relating to legacy activities and matters, including historical financial instruments or alleged obligations.
As of December 31, 2025, management does not believe any such matters require accrual or disclosure of a loss contingency.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Legal proceedings and related loss contingencies
are discussed in Note (18).&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001194">&lt;p id="xdx_802_eus-gaap--FairValueDisclosuresTextBlock_zyBzcmKcaAPi" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(17) &lt;span id="xdx_82F_zcal8v3pgM1a"&gt;Fair Value Measurements (ASC
820)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair Value of Financial Instruments&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluates and discloses the
fair value of its financial instruments in accordance with ASC 820, &lt;i&gt;Fair Value Measurement&lt;/i&gt; and ASC 825, &lt;i&gt;Financial Instruments&lt;/i&gt;.
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. The guidance establishes a three-level hierarchy for fair value measurements
based on the observability of inputs:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Level 1:&lt;/b&gt; Quoted prices in active markets for identical assets or liabilities.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Level 2:&lt;/b&gt; Observable inputs other than quoted prices included within Level 1.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Level 3:&lt;/b&gt; Unobservable inputs reflecting the Company&#x2019;s own assumptions.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The carrying amounts of cash and cash equivalents,
accounts receivable, accounts payable, and accrued expenses approximate fair value due to their short-term nature.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Investments in Marketable Securities&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the Company held
restricted, marketable equity securities that are carried at fair value based on Level 1 inputs. These securities are measured
at fair value at each reporting date, with unrealized gains and losses recognized in Other Income / (Expense) in the Statement
of Operations. The Company&#x2019;s cost basis in these securities was $&lt;span id="xdx_900_eus-gaap--EquitySecuritiesFvNiCost_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zIqyFtW6vAK5"&gt;25,500&lt;/span&gt;, and their fair value as of December 31, 2025, was
$&lt;span id="xdx_902_eus-gaap--EquitySecuritiesFvNi_iI_c20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z1WsQRFxKgDd"&gt;51,300&lt;/span&gt;. Accordingly, the Company recognized an unrealized gain of $&lt;span id="xdx_90B_eus-gaap--EquitySecuritiesFvNiUnrealizedGain_c20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z7mGnA0smuDk" title="Unrealized gain on investments in Marketable Securities"&gt;25,800&lt;/span&gt; for the year ended December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cash and Cash Equivalents&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For purposes of the Statements of Cash
Flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.&lt;/p&gt;

</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:EquitySecuritiesFvNiCost
      contextRef="AsOf2025-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001196"
      unitRef="USD">25500</us-gaap:EquitySecuritiesFvNiCost>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="AsOf2025-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001197"
      unitRef="USD">51300</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGain
      contextRef="From2025-01-012025-12-31_us-gaap_FairValueInputsLevel1Member"
      decimals="0"
      id="Fact001199"
      unitRef="USD">25800</us-gaap:EquitySecuritiesFvNiUnrealizedGain>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001201">&lt;p id="xdx_805_eus-gaap--LegalMattersAndContingenciesTextBlock_zKgwZcWMcD41" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(18) &lt;span id="xdx_825_zK3g48UOGS4c"&gt;Legal Proceedings / Litigation Reserves&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, the Company was
not a party to any pending or threatened legal proceedings that are expected to have a material effect on its financial condition,
results of operations, or cash flows.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In accordance with ASC 450, &lt;i&gt;Contingencies&lt;/i&gt;,
the Company evaluates potential legal exposures and records a liability when it is probable that a loss has been incurred and the
amount of loss can be reasonably estimated. As of December 31, 2025, &lt;span id="xdx_909_eus-gaap--LossContingencyAccrualAtCarryingValue_iI_do_c20251231_ziUbbPRD9GF6" title="Loss of contingencies"&gt;no&lt;/span&gt; loss contingencies have been recorded and no litigation
reserves have been established.&lt;/p&gt;

</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001203"
      unitRef="USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001205">&lt;p id="xdx_80A_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z6y9yrZzHKK6" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;(19) &lt;span id="xdx_822_zvC6Ti8TylEk"&gt;Related Party Transactions (ASC
850)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025,
the Company engaged in transactions with related parties in the ordinary course of business.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Consulting Arrangements&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During 2025, the Company received consulting
services from:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;MIS Consulting, Inc. (&#x201c;MIS&#x201d;), an entity owned and controlled by the Company&#x2019;s
President and Chief Executive Officer;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Abstract Concepts 1618 LLC (&#x201c;Abstract&#x201d;), a regularly engaged and compensated consultant
of the Company; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;CRD News LLC (&#x201c;CRD&#x201d;), an entity owned and controlled by the Company&#x2019;s President.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;MIS provides consulting services to the
Company pursuant to a consulting agreement substantially similar in form to the agreements used with other consultants. James Burgauer
serves as the designated consultant on behalf of MIS.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Abstract provides consulting services to
the Company pursuant to a consulting agreement substantially similar in form to the agreements used with other consultants. Lloyd
Hendricks III is the manager of Abstract and serves as the designated consultant servicing the Company&#x2019;s engagement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;CRD provides investor list rental, email
distribution services, list management, and related support services in the ordinary course of business. CRD also processes certain
third-party pass-through costs on behalf of the Company, which are reimbursed by the Company. No amounts were outstanding to CRD
as of December 31, 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Compensation for consulting and service
arrangements was approved by management and is reflected in the accompanying financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Regulation D Private Offering&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company commenced a private offering
of Series D Preferred Stock pursuant to Regulation D, Rule 506(c), with a date of first sale of December 31, 2024, as reported
on Form D. The offering continued through 2025 with a target raise of $&lt;span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zqV4Cmu65z69"&gt;1,500,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At the time Abstract participated in 2025,
approximately $&lt;span id="xdx_901_eus-gaap--PreferredStockSharesSubscribedButUnissuedValue_iI_c20251231_zrharNm7OT3d" title="Subscriptions Received amount"&gt;120,000&lt;/span&gt; in subscriptions had already been received from other investors.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Abstract participated in the offering and
acquired &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember_zyeSog3GKvm6"&gt;48,000&lt;/span&gt; shares of Series D Preferred Stock, with an aggregate stated value of approximately $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember_zx0Y57azS2Tf"&gt;1,200,000&lt;/span&gt;, together with &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_uShares_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember__us-gaap--BusinessAcquisitionAxis__us-gaap--SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_zWkM4p4ZdJW9"&gt;48,000&lt;/span&gt;
warrants in accordance with the terms of the offering. These Series D shares were immediately converted into &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember_zLXFM0kME5f4"&gt;1,200,000,000&lt;/span&gt; shares
of common stock pursuant to the stated conversion ratio of &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember_zSu29NdbtLt7"&gt;25,000&lt;/span&gt; shares of common stock for each share of Series D Preferred Stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Commodity Capital Advisors LLC (&#x201c;Commodity
Capital&#x201d;), an entity managed by Abstract and partially owned by Abstract and the two adult children of the Company&#x2019;s
President, also participated in the offering and acquired &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CommodityCapitalMember_zhBCLFYuawYc"&gt;7,200&lt;/span&gt; shares of Series D Preferred Stock, with an aggregate stated value
of approximately $&lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CommodityCapitalMember_z3Atc0v1pb87"&gt;180,000&lt;/span&gt;, together with warrants in accordance with the terms of the offering, and immediately converted them
into &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CommodityCapitalMember_zBwoDKTt49Y8"&gt;180,000,000&lt;/span&gt; shares of the Company&#x2019;s common stock pursuant to the stated conversion ratio of &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_pid_uShares_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CommodityCapitalMember_zwHOpVHv9Akf"&gt;25,000&lt;/span&gt; shares of common
stock for each share of Series D Preferred Stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The participation by Abstract and Commodity
Capital enabled the Company to complete the $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--CommodityCapitalMember_zeyqLDZDFHaj"&gt;1,500,000&lt;/span&gt; target offering amount.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The subscription consideration for the
purchases by Abstract and Commodity Capital was satisfied through the transfer by Abstract to the Company, in full payment, of
a derivative, fixed, terminating production payment royalty interest carved solely from Abstract&#x2019;s existing royalty interest
in an external project unrelated to the Company&#x2019;s operations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the subscription transactions,
the Company granted Abstract and Commodity Capital a contractual option to repurchase the transferred royalty interests. The option
is exercisable at a price equal to 110% of the respective subscription amounts, with such repurchase price increasing at a rate
of 2% per month, compounded monthly. The repurchase feature constitutes a contractual option only and does not create any obligation
of the Company to repurchase or redeem any securities or otherwise repay any amount. The repurchase feature does not constitute
indebtedness and does not obligate the holders to exercise.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Related Party Line of Credit&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During the year ended December 31, 2025,
MIS provided working capital financing to the Company pursuant to a revolving Line of Credit Agreement dated December 1, 2025.
The Credit Line permits borrowings up to a maximum outstanding principal balance of $&lt;span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zkPDh0pxyoVl"&gt;100,000&lt;/span&gt;. Advances under the facility accrue
interest at rates agreed upon by the parties for each borrowing, but not less than the Applicable Federal Rate (AFR).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Credit Line is unsecured and payable
on demand.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, approximately
$&lt;span id="xdx_900_eus-gaap--LineOfCredit_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zoNZyp5wmvXa"&gt;6,000&lt;/span&gt; was outstanding under the Credit Line.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;During 2025, Abstract advanced approximately
$&lt;span id="xdx_904_eus-gaap--ProceedsFromRelatedPartyDebt_c20250101__20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zsR0ImiixMMc"&gt;3,000&lt;/span&gt; to the Company, which was repaid shortly thereafter.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Related Party Guarantee&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In December 2025, the Company entered into
a General Indemnity Agreement in connection with a surety bond issued by Indemnity National Insurance Company relating to the Company&#x2019;s
mineral lease operations. Under the agreement, the Company&#x2019;s President executed the indemnity in his individual capacity
as an indemnitor, thereby personally guaranteeing certain obligations of the Company under the bond. The Company did not provide
additional consideration in exchange for this personal indemnity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Routine Expense Reimbursements&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Because the Company does not maintain corporate
credit cards, the Company&#x2019;s President regularly uses personal credit facilities to pay routine business expenses on behalf
of the Company. A detailed accounting of such expenses is provided monthly, and the Company reimburses such amounts in the ordinary
course of business. These reimbursements are non-interest-bearing and are not considered financing arrangements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Outstanding Related Party Balances&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of December 31, 2025, amounts due to
related parties included:&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;approximately $&lt;span id="xdx_901_ecustom--DueToRelatedPartyCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MISMember_zHfF8AGFLZcf"&gt;7,700&lt;/span&gt; payable to MIS for consulting services rendered in the ordinary course of
business;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;approximately $&lt;span id="xdx_907_ecustom--DueToRelatedPartyCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AbstractMember_zyX5s204qW27"&gt;7,200&lt;/span&gt; payable to Abstract for consulting services rendered in the ordinary course
of business; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;approximately $&lt;span id="xdx_904_ecustom--DueToRelatedPartyCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__srt--PresidentMember_zCThz2Hz3hEc"&gt;6,923&lt;/span&gt; payable to the Company&#x2019;s President for routine business expenses charged
to personal credit facilities and reimbursable in the ordinary course of business.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These balances were unsecured and are expected
to be settled in the ordinary course of business. Amounts outstanding under the MIS Line of Credit are separate obligations governed
by the Credit Agreement described above.&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember"
      decimals="0"
      id="Fact001207"
      unitRef="USD">1500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PreferredStockSharesSubscribedButUnissuedValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001209"
      unitRef="USD">120000</us-gaap:PreferredStockSharesSubscribedButUnissuedValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_AbstractMember"
      decimals="INF"
      id="Fact001210"
      unitRef="Shares">48000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_AbstractMember"
      decimals="0"
      id="Fact001211"
      unitRef="USD">1200000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-12-31_custom_AbstractMember_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"
      decimals="INF"
      id="Fact001212"
      unitRef="Shares">48000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_AbstractMember"
      decimals="INF"
      id="Fact001213"
      unitRef="Shares">1200000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_AbstractMember"
      decimals="INF"
      id="Fact001214"
      unitRef="Shares">25000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_CommodityCapitalMember"
      decimals="INF"
      id="Fact001215"
      unitRef="Shares">7200</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_CommodityCapitalMember"
      decimals="INF"
      id="Fact001216"
      unitRef="Shares">180000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-01-012025-12-31_us-gaap_SeriesDPreferredStockMember_custom_CommodityCapitalMember"
      decimals="0"
      id="Fact001217"
      unitRef="USD">180000000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-01-012025-12-31_us-gaap_CommonStockMember_custom_CommodityCapitalMember"
      decimals="INF"
      id="Fact001218"
      unitRef="Shares">25000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2025-01-012025-12-31_custom_CommodityCapitalMember"
      decimals="0"
      id="Fact001219"
      unitRef="USD">1500000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001221"
      unitRef="USD">100000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="AsOf2025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001222"
      unitRef="USD">6000</us-gaap:LineOfCredit>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2025-01-012025-12-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001223"
      unitRef="USD">3000</us-gaap:ProceedsFromRelatedPartyDebt>
    <rite:DueToRelatedPartyCurrent
      contextRef="AsOf2025-12-31_custom_MISMember"
      decimals="0"
      id="Fact001224"
      unitRef="USD">7700</rite:DueToRelatedPartyCurrent>
    <rite:DueToRelatedPartyCurrent
      contextRef="AsOf2025-12-31_custom_AbstractMember"
      decimals="0"
      id="Fact001225"
      unitRef="USD">7200</rite:DueToRelatedPartyCurrent>
    <rite:DueToRelatedPartyCurrent
      contextRef="AsOf2025-12-31_srt_PresidentMember"
      decimals="0"
      id="Fact001226"
      unitRef="USD">6923</rite:DueToRelatedPartyCurrent>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact001228">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zSDmVroLBDg5" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;(20) &lt;span id="xdx_82F_zgA66X3QAOob"&gt;Subsequent Events (ASC 855)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has evaluated events subsequent
to December 31, 2025, through the date these financial statements were issued, in accordance with ASC 855, &lt;i&gt;Subsequent Events&lt;/i&gt;.
The following non-recognized subsequent events were identified:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Arizona State Land Department Lease
Renewal&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, the Company
obtained renewal of its Arizona State Land Department mineral lease. In connection with the renewal process, the Company was assessed
renewal-related amounts relating to prior periods. Certain of these amounts were paid in 2026, and discussions with the Arizona
State Land Department regarding the remaining assessments are ongoing. The renewal extends the Company&#x2019;s rights under the
lease pursuant to the terms of the agreement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Frost Bank Banking Arrangement&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, the Company
entered into a banking arrangement with Frost Bank. In connection with such arrangement, the Company&#x2019;s President personally
guaranteed certain obligations of the Company. No liability has been recorded in the accompanying financial statements related
to this guarantee.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Issuance of Contractual Purchase Rights&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, during
the month of January 2026, the Company issued additional contractual purchase rights (&#x201c;bespoke options&#x201d;) to acquire
up to 375 shares of Series C Convertible Preferred Stock pursuant to consulting and other service provider arrangements. Each share
of Series C Convertible Preferred Stock is convertible into &lt;span id="xdx_90D_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20260131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zvru1H7U9LG6" title="Convertible stock"&gt;400,000&lt;/span&gt; shares of the Company&#x2019;s common stock. Accordingly, if
fully exercised and converted, these contractual purchase rights would result in the issuance of up to &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_uShares_c20260101__20260131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zumhNI5hhVKk" title="Issuance of stock"&gt;150,000,000&lt;/span&gt; shares of common
stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These contractual purchase rights were
issued pursuant to contractual arrangements with service providers and did not result in the issuance of any preferred or common
shares as of the date of these financial statements. As of the date of issuance of these financial statements, none of these contractual
purchase rights had been exercised.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Exercise of Series C Preferred Purchase
Options&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, on March 10, 2026, the Company&#x2019;s
President exercised options to acquire &lt;span id="xdx_90F_ecustom--StockIssuedDuringPeriodSharesStocksOptionsExercised_pid_uShares_c20260101__20260310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z6aP2G9Szgsc" title="Options to acquire shares of Series C Convertible Preferred Stock exercised"&gt;125&lt;/span&gt; shares of Series C Convertible Preferred Stock at an exercise price of $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_uUSDPShares_c20260101__20260310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zqJVxYlOI6Ee" title="Exercise price per share of Series C Convertible Preferred Stock"&gt;120&lt;/span&gt; per
share. Each share of Series C Convertible Preferred Stock is convertible into &lt;span id="xdx_901_eus-gaap--ConvertiblePreferredStockSharesIssuedUponConversion_iI_pid_uShares_c20260310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_z4SRKtx7jcpe" title="Convertible Preferred Stock, Common Stock Issuable upon Conversion"&gt;400,000&lt;/span&gt; shares of the Company&#x2019;s
common stock. This event occurred subsequent to December 31, 2025, and therefore no adjustment has been made to the accompanying
consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Return and Cancellation of Series C Preferred Stock&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the first quarter of 2026, the Company
and Alpine Securities Corporation mutually agreed to the return and cancellation of 45 shares of Series C Preferred Stock that
had previously been issued in connection with investment banking and related services. The shares were returned to the Company
and cancelled. The Company expects to reverse the related stock-based compensation expense and additional paid-in capital associated
with these shares in its financial statements for the period ending March 31, 2026. This event occurred subsequent to December
31, 2025, and therefore no adjustment has been made to the accompanying consolidated financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;Other Subsequent Events&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;No other subsequent events requiring disclosure
were identified.&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="AsOf2026-01-31_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001230"
      unitRef="Shares">400000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-01-31_us-gaap_SubsequentEventMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001232"
      unitRef="Shares">150000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <rite:StockIssuedDuringPeriodSharesStocksOptionsExercised
      contextRef="From2026-01-012026-03-10_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001234"
      unitRef="Shares">125</rite:StockIssuedDuringPeriodSharesStocksOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2026-01-012026-03-10_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001236"
      unitRef="USDPShares">120</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="AsOf2026-03-10_us-gaap_SubsequentEventMember_us-gaap_SeriesCPreferredStockMember"
      decimals="INF"
      id="Fact001238"
      unitRef="Shares">400000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-12-31" id="Fact001240">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact001241">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2025-01-01to2025-12-31" id="Fact001242">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact001243">false</ecd:Rule10b51ArrAdoptedFlag>
</xbrl>
